<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Front Nutr</journal-id><journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id><journal-title-group><journal-title>Frontiers in Nutrition</journal-title></journal-title-group><issn pub-type="epub">2296-861X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7731913</article-id><article-id pub-id-type="doi">10.3389/fnut.2020.595964</article-id><article-categories><subj-group subj-group-type="heading"><subject>Nutrition</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Natural Compounds With Antibacterial Activity Against <italic>Cronobacter</italic> spp. in Powdered Infant Formula: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Polat Yemi&#x0015f;</surname><given-names>G&#x000f6;k&#x000e7;e</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Delaquis</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/109260/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Food Engineering, Sakarya University</institution>, <addr-line>Serdivan</addr-line>, <country>Turkey</country></aff><aff id="aff2"><sup>2</sup><institution>Summerland Research and Development Research Centre, Agriculture and AgriFood Canada</institution>, <addr-line>Summerland, BC</addr-line>, <country>Canada</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Maria Jo&#x000e3;o Fraqueza, University of Lisbon, Portugal</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ben Davies Tall, United States Food and Drug Administration, United States; Dejan S. Stojkovic, University of Belgrade, Serbia</p></fn><corresp id="c001">*Correspondence: Pascal Delaquis <email>pascal.delaquis@canada.ca</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Nutrition and Food Science Technology, a section of the journal Frontiers in Nutrition</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>7</volume><elocation-id>595964</elocation-id><history><date date-type="received"><day>18</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>08</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Her Majesty the Queen in Right of Canada, as represented by the Minister of Agriculture and Agri-Food Canada.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Bacteria from the genus <italic>Cronobacter</italic> are opportunistic foodborne pathogens capable of causing severe infections in neonates, the elderly and immunocompromised adults. The majority of neonatal infections have been linked epidemiologically to dehydrated powdered infant formulas (PIFs), the majority of which are manufactured using processes that do not ensure commercial sterility. Unfortunately, the osmotolerance, desiccation resistance, mild thermotolerance and wide-ranging minimum, optimum and maximum growth temperatures of <italic>Cronobacter</italic> spp. are conducive to survival and/or growth during the processing, reconstitution and storage of reconstituted PIFs. Consequently, considerable research has been directed at the development of alternative strategies for the control of <italic>Cronobacter</italic> spp. in PIFs, including approaches that employ antimicrobial compounds derived from natural sources. The latter include a range of phytochemicals ranging from crude extracts or essential oils derived from various plants (e.g., thyme, cinnamon, clove, marjoram, cumin, mint, fennel), to complex polyphenolic extracts (e.g., muscadine seed, pomegranate peel, olive oil, and cocoa powder extracts), purified simple phenolic compounds (e.g., carvacrol, citral, thymol, eugenol, diacetyl, vanillin, cinnamic acid, trans-cinnamaldehyde, ferulic acid), and medium chain fatty acids (monocaprylin, caprylic acid). Antimicrobials derived from microbial sources (e.g., nisin, other antibacterial peptides, organic acids, coenzyme Q<sub>0</sub>) and animal sources (e.g., chitosan, lactoferrin, antibacterial peptides from milk) have also been shown to exhibit antibacterial activity against the species. The selection of antimicrobials for the control of <italic>Cronobacter</italic> spp. requires an understanding of activity at different temperatures, knowledge about their mode of action, and careful consideration for toxicological and nutritional effects on neonates. Consequently, the purpose of the present review is to provide a comprehensive summary of currently available data pertaining to the antibacterial effects of natural antimicrobial compounds against <italic>Cronobacter</italic> spp. with a view to provide information needed to inform the selection of compounds suitable for control of the pathogen during the manufacture or preparation of PIFs by end users.</p></abstract><kwd-group><kwd>natural</kwd><kwd>antimicrobials</kwd><kwd><italic>Cronobacter</italic></kwd><kwd>safety</kwd><kwd>powdered infant formula</kwd></kwd-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="168"/><page-count count="15"/><word-count count="12457"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Fatal bacterial infections in neonates caused by &#x0201c;yellow-pigmented coliforms&#x0201d; were first reported in the early 1960s (<xref rid="B1" ref-type="bibr">1</xref>). Early clinical isolates were classified as strains of <italic>Enterobacter cloacae</italic> until comparative analysis by DNA&#x02013;DNA hybridization showed they belong to a distinct species that was initially named <italic>Enterobacter sakazakii</italic> (<xref rid="B2" ref-type="bibr">2</xref>). Further genomic analysis by ribotyping, amplified fragment length polymorphism and 16S rDNA sequencing eventually provided evidence to support assignment of <italic>E. sakazakii</italic> and other closely related <italic>Enterobacter</italic> species to the novel genus <italic>Cronobacter</italic> (<xref rid="B3" ref-type="bibr">3</xref>). The List of Prokaryotic names with Standing in Nomenclature (LPSN) presently includes seven species of <italic>Cronobacter</italic> with a validly published and correct name, including <italic>Cronobacter sakazakii, Cronobacter malonaticus, Cronobacter universalis, Cronobacter turicensis, Cronobacter muytjensii, Cronobacter dublinensis</italic> and <italic>Cronobacter condimenti</italic> (<ext-link ext-link-type="uri" xlink:href="https://www.bacterio.net/genus/cronobacter">https://www.bacterio.net/genus/cronobacter</ext-link>). <italic>C. sakazakii</italic> is the most frequently reported clinical isolate and is considered to be the prototype species for the genus (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). However, all <italic>Cronobacter</italic> spp. with the exception of <italic>C. condimenti</italic> have been recovered from clinical specimens (<xref rid="B6" ref-type="bibr">6</xref>). <italic>C. sakazakii</italic> and <italic>C. malonaticus</italic> are currently the major species of public health concern, followed by <italic>C. turicensis, C. universalis, C. muytjensii</italic>, and <italic>C. dublinensis</italic> (<xref rid="B5" ref-type="bibr">5</xref>). <italic>Cronobacter</italic> infections typically affect hosts with immature or compromised immune systems, primarily neonates and infants, and to a lesser extent the elderly or individuals from all age groups with underlying chronic disease. Consequently, <italic>Cronobacter</italic> spp. are considered opportunistic human pathogens. Infections in neonates can lead to septicemia, necrotizing enterocolitis or severe meningitis with estimated case-fatality rates of 10, 20, and 42%, respectively, and to severe neurological sequelae upon recovery (<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>). Symptoms of infection in adults include wound and urinary tract infections, gastroenteritis, appendicitis, conjunctivitis, biliary sepsis, pneumonia, septicemia, and osteomyelitis (<xref rid="B10" ref-type="bibr">10</xref>). <italic>Cronobacter</italic> infections were considered exceptional and sporadic occurrences until the late 1980s when several clusters were reported in neonatal care units (<xref rid="B11" ref-type="bibr">11</xref>). Clinical investigation of a landmark incident in a US hospital showed that neonates were infected by enteral administration of reconstituted powdered infant formula (PIF) (<xref rid="B12" ref-type="bibr">12</xref>). Epidemiological investigations of similar incidents in other jurisdictions have confirmed that PIFs can serve as a vehicle for the foodborne transmission of <italic>C. sakazakii</italic> to neonates (<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>). Only one suspected foodborne outbreak involving ostensibly healthy and older individuals has been reported to date. Yong et al. (<xref rid="B16" ref-type="bibr">16</xref>) presented evidence that food contaminated with <italic>Cronobacter</italic> spp. consumed in a senior high school canteen led to an outbreak of acute gastroenteritis that resulted in 124 suspected, 12 probable, and 20 confirmed cases. Molecular analysis of isolates recovered from clinical, food, or environmental samples revealed the presence of both <italic>C. sakazakii</italic> (four isolates from two sequence types determined by multilocus sequence typing) and <italic>C. malonaticus</italic> (two isolates from one sequence type). However, the whole genome sequences of two <italic>C. sakazakii</italic> isolates recovered from a food sample and a clinical specimen differed by only five single nucleotide polymorphisms, which was highly suggestive of an epidemiological link.</p><p>While <italic>Cronobacter</italic> infections remain uncommon, alarmingly high case-fatality rates in neonates and uncertainty about transmission outside hospital care settings have prompted considerable research to determine the origin, distribution and fate of this emerging foodborne pathogen in food chains. Despite these efforts, the primary habitats of <italic>Cronobacter</italic> spp. remain unknown. Infrequent isolation from livestock and limited survival in the animal gut are indicative of a non-zoonotic nature, although contamination of meat and milk have been reported (<xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B19" ref-type="bibr">19</xref>). A review and meta-analysis of data published between 2008&#x02013;14 revealed a prevalence of 5.7% in meat products and 19.0% in plant based foods or food ingredients, which is suggestive of a stronger association with plants or environments in which they are grown (<xref rid="B20" ref-type="bibr">20</xref>). Irrespective of their primary habitat, <italic>Cronobacter</italic> spp. have been isolated from diverse dehydrated food products (PIFs, infant cereals, dairy-based preparations, flours, pasta, candies, spices, herbs, and nuts), fresh or frozen vegetables, and both natural (soil, water, insects) and man-made (hospitals, households, food storage and processing facilities) environments (<xref rid="B20" ref-type="bibr">20</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>).</p><p>Current understanding about the fate of <italic>Cronobacter</italic> spp. in food systems is primarily derived from research concerned with the role of PIFs in foodborne transmission. PIFs intended to serve as complete or partial substitutes for human milk at birth or after the introduction of solid food (follow-up formulas) contain mixtures of protein, fat, carbohydrates, vitamins, minerals, and other functional ingredients (e.g., essential fatty acids, nucleotides) in proportions needed to achieve nutrient contents mandated by national or international regulatory standards. Intact bovine milk powder is the most common source of protein, although specialized formulas containing hydrolyzed casein or proteins derived from plant sources such as soy bean are used for feeding of neonates with underlying pathologies or to accommodate cultural or religious practices (<xref rid="B24" ref-type="bibr">24</xref>). Manufacture of PIF products is accomplished by spray-drying of the mixed ingredients solubilized in water (wet processes), by mixing of heat-labile ingredients with a previously spray-dried base powder (dry processes), or by a combination of both approaches (<xref rid="B25" ref-type="bibr">25</xref>). Despite the application of heat at one or more stages of these processes PIF is not a sterile food; <italic>Cronobacter</italic> spp. are routinely detected in microbiological analysis of commercial products (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). For example, a recent survey of 128 products in Latin American markets revealed a prevalence rate of 4.7% (<xref rid="B28" ref-type="bibr">28</xref>). Microbiological assessments of milk powder and PIF manufacturing environments and processes have shown that <italic>Cronobacter</italic> spp. may derive from extrinsic sources, notably dry ingredients, or intrinsically contaminated sites where specific strains may persist over long periods of time (<xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B33" ref-type="bibr">33</xref>). Moreover, most strains examined to date have shown higher resistance to potentially lethal osmotic and dessication stresses than other human pathogen belonging to the family Enterobacteriaceae. Dessication resistance likely contributes to the environmental persistence of <italic>Cronobacter</italic> spp. in some niches within manufacturing plants, and to long term survival in powdered milk and PIF (<xref rid="B34" ref-type="bibr">34</xref>&#x02013;<xref rid="B36" ref-type="bibr">36</xref>).</p><p>The suspected role of PIF in the transmission of infections has prompted examination of <italic>Cronobacter</italic> behavior during reconstitution in water and subsequent handling, including storage for later use. Incipient work by Nazarowec-White and Farber (<xref rid="B37" ref-type="bibr">37</xref>) showed that <italic>C. sakazakii</italic> could survive reconstitution with water heated to 52&#x02013;60&#x000b0;C. Data from additional studies conducted with numerous strains over a wider range of temperatures and in different substrates suggests that most <italic>Cronobacter</italic> spp. are mildly thermotolerant, although strain-associated stress tolerance or prior heat adaptation can enhance thermal stability (<xref rid="B38" ref-type="bibr">38</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>). In response to the risk implied by latent contamination of PIFs with infectious bacteria the WHO recommends reconstitution in water at a minimum temperature of 70&#x000b0;C, conditions which have been shown to reduce <italic>C. sakazakii</italic> by &#x0003e;5 log<sub>10</sub> cycles (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Reconstitution at &#x02265;70&#x000b0;C is often impractical, however, as high temperatures can lead to curdling or other undesirable organoleptic changes, cause depletion of heat sensitive nutrients, and introduce scald or burn hazards particularly in home settings (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Consequently, lower temperatures are endorsed in some jurisdictions despite experimental evidence of limited thermal inactivation at lower temperatures. Moreover, growth of <italic>C. sakazakii</italic> has been reported to occur in reconstituted PIF stored between 5.5 and 47&#x000b0;C, conditions that can occur when feeding is delayed or during storage (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Additionally, recent work has shown that <italic>C. sakazakii</italic> is readily transferred from caregiver hands and utensils to reconstituted PIF, thereby highlighting the significance of contact surfaces as reservoirs of contamination (<xref rid="B45" ref-type="bibr">45</xref>). Adherence to and biofilm formation have been demonstrated on a wide range of materials used in the manufacture of equipment, tools and utensils used in hospital and home settings (<xref rid="B46" ref-type="bibr">46</xref>&#x02013;<xref rid="B48" ref-type="bibr">48</xref>). Biofilm formation also contributes to the persistence of <italic>Cronobacter</italic> on surfaces by enhancing resistance to adverse environmental stresses, including chemicals used in cleaning and sanitation of food processing facilities and equipment (<xref rid="B49" ref-type="bibr">49</xref>).</p><p>The risk of contamination with <italic>Cronobacter</italic> spp. is an enduring food safety challenge for the PIF industry, public health authorities and consumers worldwide. Manufacturers have adopted risk mitigation strategies that primarily rely on rigorous microbiological analysis of raw materials, improved cleaning and sanitation of the manufacturing environment, and enhanced testing of finished products. Despite these efforts, levels of contamination detected through recent surveys clearly show that the risk persists (<xref rid="B28" ref-type="bibr">28</xref>). Because the modification of existing industrial processes is constrained by the heat lability of PIF ingredients, alternative non-thermal physical treatments meant to inactivate microbial contaminants without affecting ingredient stability have been investigated or are under study (reviewed in (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>)). To date, none have been adapted to the production of PIF on an commercial scale. The use of synthetic preservatives is likewise impractical due to regulatory restrictions and enduring concerns about the negative effects of man-made food additives on human health. Accordingly, natural antibacterial compounds (NACs) derived from plant, microbial or animal sources are under consideration as alternatives to synthetic chemical preservatives for the control of <italic>Cronobacter</italic> spp. in PIF. This approach is aligned with increasing consumer willingness to accept food additives and preservatives of natural origin over synthetic products (<xref rid="B52" ref-type="bibr">52</xref>). The present work is intended to provide a summary of current knowledge about NACs with antibacterial activity against <italic>Cronobacter</italic> spp., with a view to inform their application in the development of improved PIF manufacturing processes or the formulation of safer products. For example, NACs that increase the lethality of mild heat may find value in the development of alternative processes to enhance bacterial inactivation in manufacture or during reconstitution by end-users (<xref rid="B53" ref-type="bibr">53</xref>). Where possible, the mode of action, toxicological data, regulatory status and potential health benefits of specific NACs are provided.</p></sec><sec id="s2"><title>NACs From Plants With Antibacterial Activity Against <italic>Cronobacter</italic> Spp.</title><p>The scope of research on plants as sources of natural antimicrobials and their applications in food preservation or safety has expanded significantly in recent years (<xref rid="B54" ref-type="bibr">54</xref>). Plant components and extractives thereof are attractive alternative food additives because many have a long history of use, are likely to have received regulatory consent or benefit from the increasing availability of toxicological data needed to support requests for approval (<xref rid="B55" ref-type="bibr">55</xref>). Recognition of PIF as a vector for foodborne transmission has led to the assessment of numerous crude extracts, essential oils recovered by distillation of whole plants or their parts, and purified phytochemicals for the control of <italic>Cronobacter</italic> spp. (<xref rid="T1" ref-type="table">Table 1</xref>). Crude extracts obtained in water or an alcoholic solvent are generally not modified after evaporation of the liquid phase and contain several bioactive constituents. For example, a tea extract examined by Li et al. (<xref rid="B61" ref-type="bibr">61</xref>) was reported to contain catechins, flavonoids, phenolic acids, anthocyanins, malic acid, and citric acid. The latter is typical of crude plant extracts which tend to consist of complex mixtures of compounds from different classes, notably large and diverse fractions of phenolic compounds referred to collectively as polyphenolics. Most crude extracts listed in <xref rid="T1" ref-type="table">Table 1</xref> contain polyphenolics known to have antibacterial properties, although additive or synergistic effects due to co-extracted plant constituents, notably organic acids, likely contribute to overall antibacterial activity (<xref rid="B57" ref-type="bibr">57</xref>). The mode of action of crude extracts is accordingly complex, however damage to the bacterial membrane leading to loss of function and cellular integrity induced by polyphenolics contributes significantly to overall antibacterial effects (<xref rid="B83" ref-type="bibr">83</xref>). Two extracts (cocoa powder and polyphenolic tea extract) were shown to exert bacteriostatic effects and reduce the growth of <italic>Cronobacter</italic> spp. in reconstituted PIF. Crude plant extracts are economically attractive food additives due to their low cost of production in comparison purified phytochemicals. However, variability in antibacterial activity due to differences in composition resulting from varietal, agronomic or production factors tend to limit practical applications in foods. Concentrations of compounds with antibacterial activity may also be lower than those of co-extracted compounds that can lend undesirable physico-chemical or organoleptic properties to target food products. Similar constraints hamper food applications for essential oils, complex mixtures of volatile lipophilic terpenoids, phenylpropanoids, or short-chain aliphatic hydrocarbon derivatives (<xref rid="B84" ref-type="bibr">84</xref>). Results from four scientific reports listed in <xref rid="T1" ref-type="table">Table 1</xref> show that essential oils recovered from several aromatic plant species show antibacterial activity against <italic>Cronobacter</italic> spp. Moreover, Al-Nabulsi et al. (<xref rid="B65" ref-type="bibr">65</xref>) found that growth of <italic>C. sakazakii</italic> in reconstituted PIF was inhibited by supplementation with cinnamon or fir essential oils and that mixtures of the two were bactericidal, reducing populations by &#x0003e;6 log<sub>10</sub> after 3 h of incubation at 37&#x000b0;C. These results support the widely held view that the activity of essential oils stems from additive or synergistic antimicrobial effects involving multiple components, and underscores the need to determine concentrations of key active compounds needed to ensure consistent activity in foods (<xref rid="B85" ref-type="bibr">85</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Plant-derived crude extracts, essential oils, and purified phytochemicals with antibacterial activity against <italic>Cronobacter</italic> spp.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"><bold>Agents with <italic>in vitro</italic> antibacterial activity</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Composition</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Demonstrated or suggested mode of action</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Antibacterial activity in PIF</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Crude extracts</td><td valign="top" align="left" rowspan="1" colspan="1">Aqueous extracts of red muscadine seed; muscadine juice</td><td valign="top" align="left" rowspan="1" colspan="1">Malic, tartaric, tannic acids; polyphenols (gallic acid, catechin, epicatechin, ellagic acid, resveratrol)</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined. Suggested synergy between components</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Cocoa powder</td><td valign="top" align="left" rowspan="1" colspan="1">Polyphenol rich</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Bacteriostatic in reconstituted PIF incubated at 37&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B58" ref-type="bibr">58</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Proanthocyanidin- rich methanolic blueberry extract; blueberry juice</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Loss of membrane integrity, altered fatty acid profile, disruption of metabolism</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B59" ref-type="bibr">59</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Methanolic extracts of black pepper and cinnamon bark</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of quorum sensing and biofilm formation at sub-inhibitory concentrations</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Polyphenolic tea extract</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Membrane damage leading to cytoplasmic leakage; pH effects</td><td valign="top" align="left" rowspan="1" colspan="1">Bacteriostatic effect in reconstituted PIF incubated at 37&#x000b0;C; enhanced at pH &#x02264; 4</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B61" ref-type="bibr">61</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Polyphenolic olive oil extract</td><td valign="top" align="left" rowspan="1" colspan="1">Hydroxytyrosol, tyrosol, phenolic acids</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of intracellular ATP, membrane depolarization, decreased protein synthesis</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B62" ref-type="bibr">62</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Polyphenolic rich pomegranate peel extract</td><td valign="top" align="left" rowspan="1" colspan="1">Elligitannins, &#x003b1;, &#x003b2;-punicalagin, ellagic acid and derivatives, punicalin</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B63" ref-type="bibr">63</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Essential oils</td><td valign="top" align="left" rowspan="1" colspan="1">Cinnamon, clove, lemongrass, laurel, oregano essential oils</td><td valign="top" align="left" rowspan="1" colspan="1">Not Determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B64" ref-type="bibr">64</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Cinnamon, fir essential oils</td><td valign="top" align="left" rowspan="1" colspan="1">Nor determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined. Suggested synergy between phenolic compounds, organic acids and other components</td><td valign="top" align="left" rowspan="1" colspan="1">Bacteriostatic effects in reconstituted PIF incubated at 37&#x000b0;C with fir and cinnamon oils; bactericidal effects with fir + cinnamon oil</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B65" ref-type="bibr">65</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Thyme, clove, ginger extracts obtained by hydrodistillation</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B66" ref-type="bibr">66</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Thyme, cinnamon, marjoram essential oils</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined. Suggested synergy between phenolic compounds</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B67" ref-type="bibr">67</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Purified phytochemicals</td><td valign="top" align="left" rowspan="1" colspan="1">Carvacrol, thymol, eugenol, diacetyl, cinnamic acid</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B68" ref-type="bibr">68</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Trans-cinnamaldehyde</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">No determined. Suggested disruption of bacterial cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Bactericidal effects in reconstituted PIF incubated at 37 and 8&#x000b0;C; Reduced resistance to acid and heat in reconstituted PIF</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Vanillin, vanillic acid</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Reduced heat resistance during reconstitution; Bactericidal effects in reconstituted PIF incubated at 21 and 10&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Caprylic acid</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane; synergistic effects when used in combination with citric acid or vanillin</td><td valign="top" align="left" rowspan="1" colspan="1">Reduced heat resistance during reconstitution; Bacteriostatic effects in reconstituted PIF incubated at 40&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B74" ref-type="bibr">74</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Citral</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of intracellular ATP, cell membrane hyperpolarization, reduction in cytoplasmic pH.</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B75" ref-type="bibr">75</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Syringic acid</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of intracellular ATP, cell membrane hyperpolarization, reduction in cytoplasmic pH.</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B76" ref-type="bibr">76</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Ferulic acid</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B77" ref-type="bibr">77</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Thymoquinone</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane; Reduced stress tolerance; Decreased motility, quorum sensing, endotoxin production, biofilm formation at sub-inhibitory concentrations</td><td valign="top" align="left" rowspan="1" colspan="1">Reduced resistance to heat during reconstitution; Reduced resistance to acid, heat, osmotic stress in reconstituted PIF</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B78" ref-type="bibr">78</xref>&#x02013;<xref rid="B80" ref-type="bibr">80</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Carvacrol + citral</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of energy maintenance, membrane repair and proton motive force at sub-inhibitory concentrations</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B81" ref-type="bibr">81</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Coenzyme Q<sub>0</sub></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of intracellular ATP; Disruption of bacterial cell membrane; inhibition of biofilm formation</td><td valign="top" align="left" rowspan="1" colspan="1">Reduced resistance to heat during PIF reconstitution;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B82" ref-type="bibr">82</xref>)</td></tr></tbody></table></table-wrap><p>Extraction and purification of NACs from plants circumvents challenges occasioned by variable crude extract or essential oil composition. Purified preparations of the phytochemicals listed in <xref rid="T1" ref-type="table">Table 1</xref> are readily available from commercial sources. Most are known to exert antimicrobial effects primarily by disruption of the bacterial cell membrane. Trans-cinnamaldehyde, vanillin, ethyl vanillin, vanillic acid, thymoquinone, and Coenzyme Q<sub>0</sub> have been shown to reduce the thermotolerance of <italic>Cronobacter</italic> spp. during reconstitution and to provide antibacterial effects during subsequent storage. Overall, the reported nature and magnitude of measured effects vary with type of compound, level of PIF supplementation and temperature. For example, Amalaradjou et al. (<xref rid="B69" ref-type="bibr">69</xref>) reported that trans-cinnamaldehyde exerts time- and temperature-dependent bactericidal activity against <italic>C. sakazakii</italic> in reconstituted PIF during storage at 4, 8, 23, and 37&#x000b0;C. In contrast, supplementation with caprylic acid could only elicit bacteriostatic effects against the same species in reconstituted PIF stored at 40&#x000b0;C (<xref rid="B74" ref-type="bibr">74</xref>). The effects of these compounds on the thermotolerance of <italic>Cronobacter</italic> are more consistent. Amalaradjou et al. (<xref rid="B70" ref-type="bibr">70</xref>) showed that complete thermal inactivation of <italic>C. sakazakii</italic> could be achieved by heating reconstituted PIF supplemented with 70 &#x003bc;M trans-cinnamaldehyde at 60&#x000b0;C for 10 min, but that longer heating times were required to achieved the same effect at lower supplementation levels or temperatures. Likewise, <italic>C. sakazakii</italic> was completely inactivated by heating reconstituted PIF supplemented with 30 mmol l<sup>&#x02212;1</sup> thymoquinone at 55&#x000b0;C for 10 min, and longer treatment times were needed to achieved the same effect at lower concentrations or temperatures (<xref rid="B78" ref-type="bibr">78</xref>). Caprylic acid (<xref rid="B73" ref-type="bibr">73</xref>), coenzyme Q<sub>0</sub> (<xref rid="B82" ref-type="bibr">82</xref>), vanillin, ethyl vanillin, and vanillic acid (<xref rid="B72" ref-type="bibr">72</xref>) have also been found to lower the thermotolerance of <italic>C. sakazakii</italic> during reconstitution. Moreover, the bactericidal activity of vanillin, ethyl vanillin, and vanillic acid were sustained during subsequent storage at 21 and 5&#x000b0;C, which illustrates that some phytochemical compounds can contribute antibacterial effects at multiple stages during the manufacture or preparation of PIF by end-users.</p><p>The volatility, susceptibility to conversion and degradation reactions, intense organoleptic character and poor solubility of many plant extracts, essentials oils or phytochemicals have long hindered wider use in food preservation. However, considerable progress has been achieved in the development of novel technologies for the delivery of food additives that are intended to overcome these limitations, notably encapsulation methods that stabilize active components and enable their release of over variable time periods, at specific temperatures or at different sites within food matrices (reviewed in (<xref rid="B86" ref-type="bibr">86</xref>)). To date, the merit of these technologies for the delivery of NACs for the control of <italic>Cronobacter</italic> in PIF remains unexplored. Encapsulation platforms that provide controlled release at temperatures applied during the manufacture, preparation or storage of reconstituted PIF could provide the means to ensure delivery when contaminants are most vulnerable to their effects or when the risk of proliferation is highest.</p></sec><sec id="s3"><title>NACs From Microbial Sources With Antibacterial Activity Against <italic>Cronobacter</italic> Spp.</title><p>Several NACs from microbial sources and their antibacterial activity against <italic>Cronobacter</italic> spp. are shown in <xref rid="T2" ref-type="table">Table 2</xref>. Probiotics, live microorganisms which when administered in adequate amounts confer a health benefit on the host, are presently used in some countries for pediatric care. Commercial PIFs products containing live preparations of <italic>Lactobacillus</italic> or <italic>Bifidobacterium</italic> spp. are available in the marketplace but the effect of probiotic supplementation on the behavior of <italic>Cronobacter</italic> spp. during or after reconstitution is unknown. The use probiotic bacteria for the explicit control of <italic>Cronobacter</italic> spp. infections was investigated by Collado et al. (<xref rid="B93" ref-type="bibr">93</xref>) who showed that species of <italic>Lactobacillus, Bifidobacterium</italic> and <italic>Streptococcus</italic> competitively excluded, inhibited and displaced <italic>C. sakazakii</italic> in a human intestinal model system. Despite evidence of their antibacterial properties, there have been few additional attempts to exploit the use of live probiotic bacteria for the control of human pathogens in PIF, likely in response to on-going controversy about the efficacy, safety, variability, quality, labeling, and lack of standards for the use of probiotic products destined for neonatal care (<xref rid="B94" ref-type="bibr">94</xref>, <xref rid="B95" ref-type="bibr">95</xref>). NACs derived from microbial sources continue to attract interest, however, notably whole inactivated cells or crude cell extracts that retain bioactivity, which have been termed &#x0201c;parabiotics&#x0201d; (<xref rid="B96" ref-type="bibr">96</xref>), or purified soluble factors (products or metabolic byproducts) secreted by live microorganisms or released after lysis, which have been described as &#x0201c;postbiotics&#x0201d; (<xref rid="B97" ref-type="bibr">97</xref>). Hayes et al. (<xref rid="B87" ref-type="bibr">87</xref>) showed that addition of a crude cell-free extract prepared from a caseinate medium fermented by the common probiotic bacterium <italic>Lactobacillus acidophilus</italic> could inhibit <italic>C. sakazakii</italic> in reconstituted PIF. Antimicrobial effects were attributed to antimicrobial peptides (caseicin A &#x00026; B) derived from the degradation of bovine casein by microbial enzymes. Charchoghlyan et al. (<xref rid="B89" ref-type="bibr">89</xref>) found that a purified heat inactivated aqueous extract of skim milk fermented with a commercial probiotic strain of <italic>Lactobacillus acidophilus</italic> used to supplement PIF also inactivated <italic>C. sakazakii</italic> in the reconstituted product stored at 37&#x000b0;C. The composition of the extract was not provided by the authors of the study, who offered that acids released during fermentation were likely responsible for antibacterial effects. A similar conclusion was reached by Kim et al. (<xref rid="B90" ref-type="bibr">90</xref>) in reference to the mechanism responsible for inhibition of <italic>C. sakazakii</italic> by cell free supernatants of laboratory grown cultures of <italic>Lactobacillus kefiri</italic> and <italic>Lactobacillus kefiranofaciens</italic> isolated from kefir, and a commercial probiotic strain of <italic>Bifidobacterium longum</italic>. It must be noted here that current international (e.g., CODEX STAN 72-1981) or national standards for ingredients or additives permissible in PIF do not include D-lactic acid, a metabolic by-product released during fermentation by <italic>L. acidophilus, L., kefiri</italic>, and <italic>L. kefiranofaciens</italic>. Probiotic bacteria such as <italic>Bifidobacterium longum</italic> that do not produce D-lactic acid could be used to circumvent the problem. However, uncertainty concerning the composition and variability in bioactive components in crude cell-free extracts derived from any microbial species is a barrier to broader food applications. The problem can be avoided by the isolation, purification and characterization of antimicrobial compounds that accumulate in growth media. For example, the examination of cell-free supernatants from laboratory grown cultures of <italic>L. acidophilus</italic> and <italic>L. casei</italic> by Awaisheh et al. (<xref rid="B88" ref-type="bibr">88</xref>) revealed that both species produce heat-labile bacteriocins, proteinaceous or peptidic molecules with antibacterial activity against <italic>C. sakazakii</italic>. To date, nisin is the only antibacterial peptide to receive close scrutiny for enhancement of PIF safety. Nisin, a polycyclic peptide bacteriocin produced by <italic>Lactococcus lactis</italic>, is presently permitted as a food additive in over 50 countries, primarily for the extension of shelf-life or the prevention of quality defects in dairy products (<xref rid="B98" ref-type="bibr">98</xref>). The antibacterial activity of nisin is mainly due to depolarizing effects and consequent disruption of the cytoplasmic cell membrane. Gram-positive bacteria are more resistant to this effect than Gram-negative bacteria in which the cell membrane is surrounded by a lipopolysaccharide outer membrane. Consequently, means to destabilize and permeabilize the outer membrane by physical (mild heat, sonication) or chemical means (metal chelators, EDTA, disodium pyrophosphate, sodium hydrogen orthophosphate, citric acid, lactic acid) are often used in conjunction with nisin to improve antibacterial activity against Gram-negative bacteria such as <italic>Cronobacter</italic> spp. Al-Nabulsi et al. (<xref rid="B99" ref-type="bibr">99</xref>) found that reconstitution of PIF at 55&#x000b0;C did not significantly improve the antibacterial activity of nisin against 5 <italic>Cronobacter</italic> strains. In contrast, Campion et al. (<xref rid="B92" ref-type="bibr">92</xref>) observed strong bactericidal activity against <italic>C. sakazakii</italic> in reconstituted PIF supplemented with a commercial nisin preparation (Nisaplin) and citric acid, a food additive permitted in infant formula. This finding suggests that antibacterial strategies based on synergistic effects between nisin and additives compliant with regulatory standards for PIF merit further investigation. Corresponding efforts should be directed at the assessment of alternative sources of antimicrobial peptides, including other commercial bacteriocin products or the array of peptides derived from probiotics or bacterial starter cultures described in the scientific literature (<xref rid="B100" ref-type="bibr">100</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Natural antimicrobials from microbial sources with antibacterial activity against <italic>Cronobacter</italic> spp.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Antibacterial activity <italic>in vitro</italic></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Demonstrated or suggested mode of action</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Antibacterial activity in PIF</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell-free extract of <italic>Lactobacillus acidophilus</italic> grown in caseinate, containing antimicrobial peptides caseicin A &#x00026; B</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Bactericidal effect in reconstituted PIF incubated at 37 and 6&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B87" ref-type="bibr">87</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heat-labile bacteriocins in cell-free extracts of <italic>Lactobacillus casei</italic> and <italic>L. acidophilus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Bacteriostatic effect in reconstituted PIF incubated at 37&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B88" ref-type="bibr">88</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell-free extract of <italic>Lactobacillus acidophilus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Not determined. Suggested effect of organic acids released by <italic>Lactobacillus acidophilus</italic> during growth</td><td valign="top" align="left" rowspan="1" colspan="1">Bactericidal effect in reconstituted PIF incubated at 37&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B89" ref-type="bibr">89</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell-free extracts of <italic>Lactobacillus kefiri</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B90" ref-type="bibr">90</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell-free extracts of <italic>Lactobacillus acidophilus, L. bulgaricus L. casei rhamnosus, L. paracasei L. salivarius</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B91" ref-type="bibr">91</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nisin +citric acid</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Bactericidal effect in reconstituted PIF incubated at room temperature when mixed with citric acid</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B92" ref-type="bibr">92</xref>)</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>NACs From Animal Sources With Antibacterial Activity Against <italic>Cronobacter</italic> Spp.</title><p>Selected NACs from animal sources and their antibacterial activity against <italic>Cronobacter</italic> spp. are shown in <xref rid="T3" ref-type="table">Table 3</xref>. The first natural antimicrobial derived from animal sources considered for the control of <italic>Cronobacter</italic> spp. in PIF was lactoperoxidase, an enzyme that occurs in milk, colostrum, tears, saliva, and other mammalian secretions (<xref rid="B101" ref-type="bibr">101</xref>). Lactoperoxidase catalyzes the oxidation of thiocyanate to hypothiocyanous acid and hypothiocyanate by H<sub>2</sub>O<sub>2</sub> and generates intermediate products with antimicrobial properties. The &#x0201c;lactoperoxidase (LPO) system&#x0201d; relies on the interaction of all three components which must be present in sufficient amounts to initiate the reaction. Gurtler and Beuchat (<xref rid="B101" ref-type="bibr">101</xref>) showed that addition of bovine LPO to reconstituted milk-based PIF could inhibit the growth of <italic>C. sakazakii</italic> at temperatures &#x0003e;21&#x000b0;C. However, use of the LPO system in PIF is hindered by the need for addition of an exogenous source of thiocyanate, a known goitrogen (<xref rid="B106" ref-type="bibr">106</xref>). Another antibacterial protein also found in mammalian secretory fluids, lactoferrin, is not bound by this restriction. Lactoferrin, a small glycoprotein, inhibits bacteria indirectly by the sequestration of iron from the environment and through direct antibacterial effects resulting from disruption of the outer Gram-negative bacterial membrane, leading to alterations in cell permeability and loss of viability (<xref rid="B107" ref-type="bibr">107</xref>). Indirect antibacterial effects mediated by alteration of host innate immune functions have also been reported (<xref rid="B108" ref-type="bibr">108</xref>). Bovine milk is the most common source of lactoferrin and several manufacturers provide purified preparations for use in pharmaceutical, cosmetic and food applications, including the supplementation of PIF. Usage of lactoferrin supplemented PIF is common in some countries for the prevention of neonatal sepsis and necrotizing enterocolitis despite continued uncertainty about efficacy (<xref rid="B109" ref-type="bibr">109</xref>). Experimentation <italic>in vitro</italic> has shown that <italic>Cronobacter</italic> spp. are highly susceptible to the direct antibacterial effects of lactoferrin (<xref rid="B99" ref-type="bibr">99</xref>). However, the same authors found no evidence of antibacterial effects in reconstituted PIF during storage at 10, 21, or 37&#x000b0;C, a result ascribed to interactions with food components that reduced the activity of lactoferrin, notably the divalent cations Ca<sup>2+</sup>, Mg<sup>2+</sup>, and Fe<sup>3+</sup>. Harouna et al. (<xref rid="B102" ref-type="bibr">102</xref>) attempted to improve the activity of lactoferrin by saturation with iron cations but the saturated form of the protein had no measurable antibacterial effect against <italic>C. sakzakii</italic>. Numerous novel antimicrobial peptides with enhanced antimicrobial activity have been synthesized through chemical or enzymatic hydrolysis of lactoferrin (<xref rid="B110" ref-type="bibr">110</xref>). Harouna et al. (<xref rid="B103" ref-type="bibr">103</xref>) prepared lactoferrin hydrolysates using pepsin, chymosin and microbial rennet that exhibited enhanced antibacterial activity against <italic>C. sakazakii</italic> in a microbiological medium. None were effective in reconstituted PIF at 37&#x000b0;C, however, which provided further evidence that PIF ingredients interfere with the activity of proteic or peptidic antimicrobials. The majority of NACs from animal sources considered for the enhancement of PIF safety have been derived from bovine milk. Antimicrobial peptides have been detected in the milk of other food animal species including sheep and goats (<xref rid="B111" ref-type="bibr">111</xref>). A recent report that growth of <italic>C. sakazakii</italic> is inhibited by strong, inherent antibacterial factors in camel milk suggested they are likely derived from the protein component (<xref rid="B105" ref-type="bibr">105</xref>). A database assembled by Wang et al. (<xref rid="B112" ref-type="bibr">112</xref>) lists 1,972 known antimicrobial peptides from animal sources, in addition to 321 from plants and many from fungi, protists or other life forms. One antimicrobial peptide from a non-bovine source, bicarinalin from ants, exhibited stronger bactericidal effects against <italic>C. sakazakii</italic> than ampicillin and tetracycline (<xref rid="B104" ref-type="bibr">104</xref>). Clearly, animals are a rich and largely untapped source of NACs that could find value in the enhancement of PIF safety.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Natural antimicrobials from animal sources with antibacterial activity against <italic>Cronobacter</italic> spp.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Antibacterial activity <italic>in vitro</italic></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Demonstrated or suggested mode of action</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Antibacterial activity in PIF</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Lactoperoxidase</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined; Suggested result of oxidation of sulfhydryl groups on enzymes and proteins in cytoplasmic membranes.</td><td valign="top" align="left" rowspan="1" colspan="1">Bactericidal effect in reconstituted PIF incubated at 21, 30, 37&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B101" ref-type="bibr">101</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bovine lactoferrin</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Limited bacteriostatic effect when high concentrations were added to reconstituted PIF stored at 21&#x000b0;C; no effect at 10&#x000b0;C</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B99" ref-type="bibr">99</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Iron-saturated bovine lactoferrin</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined. Suggested destabilization of bacterial membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined; Limited bacteriostatic activity in whey</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B102" ref-type="bibr">102</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cationic peptides from enzymatic hydrolysis of lactoferrin</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Limited bacteriostatic effects in combination with native lactoferrin</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B103" ref-type="bibr">103</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bicarinalin (cationic peptide from ants)</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of bacterial cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B104" ref-type="bibr">104</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Camel milk</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="left" rowspan="1" colspan="1">Not determined</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B105" ref-type="bibr">105</xref>)</td></tr></tbody></table></table-wrap></sec><sec id="s5"><title>Nutritional, Toxicological, and Regulatory Considerations</title><p>Commercial PIF products are subject to regulations and regulatory oversight administered by national governments. All are based on the Codex Alimentarius &#x0201c;Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants (CODEX STAN 72-1981),&#x0201d; which provides recommendations regarding the essential composition, nutritional quality and additives in formula. CODEX recommendations are adopted by national governments in various ways, but there is general consistency in the application of compositional and nutritional quality standards for PIF across the globe. In contrast, some disparities exist with respect to the use of additives due to variable legislative, legal or regulatory frameworks within different jurisdictions. In the United States, food ingredients are subject to provisions in the Code of Federal Regulations. Ingredients that are not listed in the Code can obtain Generally Recognized as Safe (GRAS) designation through a notification program which requires petitioners to provide historical and scientific evidence that a substance added to food is considered safe and suitable for exemption from the food additive tolerance requirements of the United States Food and Drug Administration. The GRAS status of selected NACs with antibacterial activity against <italic>Cronobacter</italic> spp. in PIF is shown in <xref rid="T4" ref-type="table">Table 4</xref>, along with health benefits that have been ascribed to them and pertinent toxicological data. The authors recognize that lack of knowledge about the metabolism of food additives old or new, difficulties in determining accurate levels of exposure, and susceptibility to toxicity have historically hindered safety assessments in the neonatal context (<xref rid="B150" ref-type="bibr">150</xref>). Likewise, the purported health benefits noted in <xref rid="T4" ref-type="table">Table 4</xref> are largely derived from animal studies or human feeding trials conducted with children or adults, and extrapolation of results to the neonatal situation is challenging.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Suggested health-promoting effects, toxicological data, safety assessments and regulatory status of selected natural antimicrobial compounds with antibacterial activity against <italic>Cronobacter</italic> spp. in PIF.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>NAC</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Reported Health Benefits</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Toxicology/safety assessments</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Regulatory status</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Cocoa powder</td><td valign="top" align="left" rowspan="1" colspan="1">Prevention of cardiovascular disease; improved blood pressure regulation, insulin resistance and vascular function; increased production of nitric oxide (NO) and antioxidant effects including delayed oxidation of low-density lipoprotein cholesterol, inhibition of ultraviolet-induced DNA oxidation (<xref rid="B113" ref-type="bibr">113</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic dietary exposure not carcinogenic to rats (<xref rid="B114" ref-type="bibr">114</xref>); No evidence of toxic effects on the heart, liver, kidney, lungs, testis, and spleen of rats fed high oral doses (<xref rid="B115" ref-type="bibr">115</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Food ingredient.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Polyphenolic tea extracts</td><td valign="top" align="left" rowspan="1" colspan="1">Black teas: prevention of cancer; obesity, antioxidant protective and anti-hyperglycemic effects (<xref rid="B116" ref-type="bibr">116</xref>).<break/> Green teas: prevention of cancer, obesity, metabolic syndrome, type 2 diabetes, cardiovascular diseases (<xref rid="B117" ref-type="bibr">117</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Suspected cytotoxicity of epigallocatechin 3-gallate, the major catechin present in green tea, in adults and children (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Generally Recognized as Safe (GRAS) according to US Code of Federal Regulations (USCFR), Title 21, &#x000a7; 182.20, Essential oils, oleoresins (solvent-free), and natural extractives (including distillates (<xref rid="B119" ref-type="bibr">119</xref>). Listed as dietary supplements under the Health and Education Act of 1994 (<xref rid="B120" ref-type="bibr">120</xref>).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cinnamon essential oil, trans-cinnamaldehyde</td><td valign="top" align="left" rowspan="1" colspan="1">Antitumour, anti-inflammatory and analgesic, anti-diabetic and anti-obesity, antibacterial and antiviral, cardiovascular protective, cytoprotective, neuroprotective, and immunoregulatory effects (<xref rid="B121" ref-type="bibr">121</xref>); Treatment of high blood glucose and lipid levels and other symptoms of the metabolic syndrome, polycystic ovary syndrome (PCOS) and inflammatory disorders (<xref rid="B122" ref-type="bibr">122</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Occasional gastrointestinal disorders and allergic reactions reported (<xref rid="B121" ref-type="bibr">121</xref>); Potential nephrotoxicity and hepatotoxicity at higher than recommended daily dose (<xref rid="B123" ref-type="bibr">123</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Trans-cinnamaldehyde: USCFR GRAS, &#x000a7; 182.60.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vanillin, ethyl vanillin, vanillic acid</td><td valign="top" align="left" rowspan="1" colspan="1">Antioxidant, anti-inflammatory, antisickling, antimicrobial, and hypolipidemic effects; prevention of cancer, periodontal disease, and bone deterioration (<xref rid="B124" ref-type="bibr">124</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Lack of toxicity at approved levels of intake in foods; Vanillin may induce bronchoconstriction in asthmatics (<xref rid="B125" ref-type="bibr">125</xref>), contact dermatitis at high concentrations (<xref rid="B126" ref-type="bibr">126</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Vanilla extracts: USCFR GRAS, &#x000a7;182.20; Vanillin and ethyl vanillin: USCFR GRAS &#x000a7;182.60 (Synthetic flavoring substances and adjuvants, can be from natural sources); Vanillic acid is not listed in the US FDA Code of Federal Regulations; evaluation by the FAO/WHO Expert Committee on Food Additives (JECFA no. 959) yielded &#x0201c;no safety concern at current levels of intake when used as a flavoring agent&#x0201d; (<xref rid="B127" ref-type="bibr">127</xref>).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caprylic acid</td><td valign="top" align="left" rowspan="1" colspan="1">Role in the prevention of infection and inflammation as part of lipid emulsions used in parenteral feeding of neonates (<xref rid="B128" ref-type="bibr">128</xref>); Prevention of obesity by decreasing energy intake, possible effects on appetite (<xref rid="B129" ref-type="bibr">129</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">No evidence of toxic effects at doses up to 10% in the diet (<xref rid="B130" ref-type="bibr">130</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">USCFR GRAS &#x000a7;184.1025; Available as a dietary supplement.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Thymoquinone</td><td valign="top" align="left" rowspan="1" colspan="1">Anti-inflammatory, antimicrobial, antiparasitic, antioxidant, antihyperglycemic, and anticancer properties (<xref rid="B131" ref-type="bibr">131</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Concentration dependant <italic>in vitro</italic> hepato-toxic effects (<xref rid="B132" ref-type="bibr">132</xref>); No evidence of cytotoxicity in rats (<xref rid="B133" ref-type="bibr">133</xref>); no evidence of toxicity in humans at daily oral doses up to 28 g/kg (<xref rid="B134" ref-type="bibr">134</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Source plant (<italic>Nigella sativa</italic> L., black seed or black cumin), is listed by USCFR GRAS in &#x000a7; 182.10 (Spices and other natural seasonings and flavorings); Source plant extracts listed as dietary supplements under the Health and Education Act of 1994 (<xref rid="B120" ref-type="bibr">120</xref>).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coenzyme Q<sub>0</sub></td><td valign="top" align="left" rowspan="1" colspan="1">Antitumor, anti-inflammatory and anti-angiogenic effects (<xref rid="B82" ref-type="bibr">82</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">No evidence of toxicological effects from dietary supplements (<xref rid="B135" ref-type="bibr">135</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Not presently permitted as a food additive. Available as a dietary supplement.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nisin</td><td valign="top" align="left" rowspan="1" colspan="1">Prevention of dental caries (<xref rid="B136" ref-type="bibr">136</xref>); anticancer and antibacterial (<xref rid="B137" ref-type="bibr">137</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Effects on the cytoskeleton of keratinocytes derived from normal epithelium; increased blood cholesterol concentrations in rats (<xref rid="B138" ref-type="bibr">138</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">USCFR GRAS, &#x000a7;184.1538, antimicrobial for specified uses which do not currently include PIF.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lactoperoxidase</td><td valign="top" align="left" rowspan="1" colspan="1">Inactivation of carcinogens (<xref rid="B139" ref-type="bibr">139</xref>); Contributions to cytotoxic effects against human cancer cells (<xref rid="B140" ref-type="bibr">140</xref>); Prevention of bone resorption through osteoclastogenesis (<xref rid="B141" ref-type="bibr">141</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Preparations derived from bovine milk could contain proteins which may be allergenic for sensitive individuals.</td><td valign="top" align="left" rowspan="1" colspan="1">USCFR GRAS notice granted for lactoperoxidase system as a processing aid for dairy products pursuant to &#x000a7; 170.30 (Eligibility for classification as generally recognized as safe (GRAS).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bovine lactoferrin</td><td valign="top" align="left" rowspan="1" colspan="1">Contributions to cytotoxic effects against human cancer cells (<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B142" ref-type="bibr">142</xref>); Contribution to gut health and immune development in neonates (<xref rid="B143" ref-type="bibr">143</xref>, <xref rid="B144" ref-type="bibr">144</xref>); Prevention of acute gastrointestinal and respiratory symptoms in children aged 12&#x02013;32 months (<xref rid="B145" ref-type="bibr">145</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">No adverse effects in rats fed 2,000 mg/kg/day bovine lactoferrin for 13 days (<xref rid="B146" ref-type="bibr">146</xref>); Considered safe for human consumption (<xref rid="B147" ref-type="bibr">147</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">USCFR GRAS notice granted for cow's milk-derived lactoferrin as an additive ingredient for PIF pursuant to &#x000a7;170.35 (Affirmation of generally recognized as safe (GRAS) status).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell free extracts of <italic>Lactobacillus</italic> spp.</td><td valign="top" align="left" rowspan="1" colspan="1">Variable, depending on species and nature of extracts; Management of intestinal, respiratory diseases (<xref rid="B148" ref-type="bibr">148</xref>); Cytotoxic effects against human cancer cells (<xref rid="B149" ref-type="bibr">149</xref>); Immunomodulation, anti-inflammatory, antiproliferative, hepatoprotective effects (<xref rid="B97" ref-type="bibr">97</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">No evidence of adverse effects from oral use.</td><td valign="top" align="left" rowspan="1" colspan="1">USCFR GRAS notices have been granted for some cell free extracts; Several are available as a dietary supplements.</td></tr></tbody></table></table-wrap><p>All NACs from plant sources with antibacterial activity in PIF listed in <xref rid="T4" ref-type="table">Table 4</xref>, with the exception of caprylic acid, are either purified phenolic compounds or contain high concentrations thereof. Vanillin, ethyl vanillin, and trans-cinnamaldehyde have GRAS status, and are widely consumed in food and nutritional supplements. Several vanilla-flavored PIF products containing natural and artificial flavors were once available in the marketplace but have since been withdrawn, although vanilla flavored &#x0201c;toddler&#x0201d; formula is still sold in North America. Whether the level of vanillin or ethyl vanillin supplementation used in these products was sufficient to achieve antibacterial effects against <italic>Cronobacter</italic> during PIF reconstitution or storage, as reported by Polat Yemi&#x0015f; et al. (<xref rid="B72" ref-type="bibr">72</xref>) is unknown. Supplementation of PIF with cocoa powder was also discontinued several years ago. The antibacterial activity of cocoa powder against <italic>C. sakzakii</italic> in reconstituted PIF described by Pina-P&#x000e9;rez et al. (<xref rid="B58" ref-type="bibr">58</xref>) was likely derived from polyphenols, many of which are known to interact with and damage the bacterial cell membrane (<xref rid="B83" ref-type="bibr">83</xref>). Polyphenols encompass several groups of compounds including phenolic acids and flavonoids, primarily flavanols present as monomeric epicatechin, catechin, and their oligomers referred to as proanthocyanidins. Research on the nutritional effects of moderate cocoa consumption suggests that the benefits likely outweigh the risks, and that beneficial effects on health are primarily derived from flavanol-mediated protection against oxidative insult by the modulation of oxygen radical generation and antioxidant enzyme and non-enzyme defenses (<xref rid="B151" ref-type="bibr">151</xref>, <xref rid="B152" ref-type="bibr">152</xref>). There is compelling evidence that most polyphenols are largely beneficial to human health, principally for the prevention and management of chronic diseases (<xref rid="B153" ref-type="bibr">153</xref>). On the other hand, the pharmacological properties of some polyphenols introduce concerns about their safety in products intended for use by infants. Isoflavones (genistein, daidzein, and glycitein) derived from soya beans are known activators of estrogen receptors with demonstrable effects on reproductive and endocrine functions in animal models (<xref rid="B154" ref-type="bibr">154</xref>). All soy-protein based PIFs contain isoflavones, mainly genistein, but no clear consensus has emerged regarding the short or long term implications of long-term dietary exposure on the development of infants (<xref rid="B155" ref-type="bibr">155</xref>, <xref rid="B156" ref-type="bibr">156</xref>). In contrast, consumption of the medium length straight chain fatty acid caprylic acid (octanoic acid) is considered to be comparatively free of toxicological risk (<xref rid="B130" ref-type="bibr">130</xref>). Caprylic acid is found naturally in the milk of mammals including humans (<xref rid="B157" ref-type="bibr">157</xref>) and in infant formulas as part of the medium chain triglyceride component contributed by vegetable fat, or increasingly bovine milk fat (<xref rid="B158" ref-type="bibr">158</xref>). Choi et al. (<xref rid="B74" ref-type="bibr">74</xref>) showed that low concentrations of caprylic acid in conjunction with citric acid completely inactivated <italic>C. sakazakii</italic> in PIF during reconstitution at the relatively low temperature of 45&#x000b0;C. A GRAS compound, it is used as an additive in a range of foods as an adjuvant or, interestingly, as a flavoring agent despite having an odor described as &#x0201c;slightly unpleasant and rancid-like.&#x0201d; Similarly, the monoterpene diketone thymoquinone, also a GRAS compound, could inactivate <italic>C. sakazakii</italic> during reconstitution (<xref rid="B78" ref-type="bibr">78</xref>) but it has a bitter taste and a &#x0201c;pencil-like&#x0201d; odor (<xref rid="B159" ref-type="bibr">159</xref>). The ubiquinone coenzyme Q<sub>0</sub> is the only ordorless and tasteless NAC from non-microbial or animal sources identified to date with antibacterial activity against <italic>Cronobacter</italic> spp. Coenzyme Q<sub>0</sub> extracted from the AC mushroom (<italic>Antrodia cinnamomea)</italic>, a parasitic fungus that grows of the camphor tree, has a long history of use in traditional medicine but has only recently been considered for food applications. Toxicological assessment of supplements prepared from the fungus suggest they are safe for human consumption (<xref rid="B132" ref-type="bibr">132</xref>). However, toxicological assessments of the purified compound are lacking and coenzyme Q<sub>0</sub> does not currently have GRAS status.</p><p>The chemistry, biology, toxicology, pharmacokinetic properties, and functionality of nisin as a food preservative have been extensively investigated. A recent reassessment of toxicological data by the European Food Safety Authority (EFSA) reaffirmed the safety of nisin as a food additive (<xref rid="B160" ref-type="bibr">160</xref>). Activity against <italic>Cronobacter</italic> spp. in PIF relies on synergism with citric acid (<xref rid="B92" ref-type="bibr">92</xref>), but the latter is a permitted additive. Hence, there appear to be few regulatory impediments to the use of nisin in foods destined for infants. As noted above, antibacterial activity of lactoperoxidase, another GRAS food additive that is used worldwide for milk preservation, is dependent on a source of thiocyanate, which Gurtler and Beuchat (<xref rid="B101" ref-type="bibr">101</xref>) provided exogenously in the form of sodium thiocyanate. Thiocyanates are ubiquitous in food products, however, and it is unfortunate that no attempt was made to determine if endogenous levels could have sustained the reaction. Evidence in support of this presumption was provided by Banks and Board (<xref rid="B161" ref-type="bibr">161</xref>) who found that lactoperoxidase catalyzed degradation of endogenous thiocyanates reduced the growth of <italic>Enterococcus, Pseudomonas</italic> spp. and Enterobacteriaceae in reconstituted PIF stored at 30&#x000b0;C for 48 h, which coincided with the depletion of free SCN- ions. These observations suggest that the value of lactoperoxidase for the control of <italic>Cronobacter</italic> spp. in PIF merits further investigation. There are also few regulatory obstacles to the application of lactoferrin in PIF since it is already in use for therapeutic purposes, disease prevention or health promotion in neonates (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B143" ref-type="bibr">143</xref>, <xref rid="B162" ref-type="bibr">162</xref>), and is available in highly purified forms safe for use in infant foods (<xref rid="B163" ref-type="bibr">163</xref>). Cell-free extracts derived from microbial cultures present greater regulatory challenges as noted above due to the multiplicity of bioactive compounds and variable composition of extracts which add complexity to toxicological assessments. In this context, the selection of candidate microorganisms for the production of cell free-extracts among those already permitted as probiotics in PIF or that are considered GRAS on the basis of historical, safe use in food fermentations is highly advisable.</p></sec><sec id="s6"><title>Conclusions and Future Prospects</title><p>Societal concerns and regulatory response to the risk of exposure to harmful food chemicals in early life provide strong impetus to pursue the search for alternatives. Research on NACs with antibacterial activity against <italic>Cronobacter</italic> spp. has shown that several could find value in the control of this hazardous pathogen in PIF. However, technological obstacles to practical applications persist and means to overcome them must be the focus of future research in the field. The delivery of NACs with strong antibacterial activity to food systems is often hampered by limited solubility in aqueous matrices, instability, reactions with other food components or adverse effects on sensory properties. For example, the low solubility, volatility, intense sensory characteristics, and reactivity of phenolic compounds and essential oils often hinders their incorporation in foods. Adverse effects on the sensory quality of PIF are a notable concern in light of evidence that exposure to flavors modulates neonatal feeding behavior and food acceptability and choice later in life (<xref rid="B164" ref-type="bibr">164</xref>, <xref rid="B165" ref-type="bibr">165</xref>). Recent progress in the use of biopolymers from natural sources for the design of innovative encapsulation systems that provide means to deliver effective yet reduced doses of antibacterial agents, protect active ingredients from undesirable reactions, and provide controlled, quantitative release into food matrices will undoubtedly promote the development of delivery strategies that overcome constraints on both the choice and application of NACs (<xref rid="B166" ref-type="bibr">166</xref>, <xref rid="B167" ref-type="bibr">167</xref>). The selection of suitable NACs must also be guided by careful consideration of the regulatory framework governing PIF composition, specifically the use of additives. In the near term, single compounds for which nutritional and toxicological data are available should take preference over preparations likely to contain multiple bioactive compounds. The latter remain eminently worthy of study, however, as possible sources of novel NACs. As a final note, it must be emphasized that the NACs described in the present work were derived from a limited number of animal, plant and bacterial species. Future efforts should be directed at the assessment of additional sources of NACs for the control of <italic>Cronobacter</italic> spp., such as mushroom species known to contain compounds with antibacterial activity against other foodborne pathogens (<xref rid="B168" ref-type="bibr">168</xref>).</p></sec><sec id="s7"><title>Author Contributions</title><p>GP and PD equally contributed to a review of the scientific literature, collection of relevant references, writing, and editing of the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec id="s8"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urmenyi</surname><given-names>AM</given-names></name><name><surname>White-Franklin</surname><given-names>A</given-names></name></person-group>. <article-title>Neonatal death from pigmented coliform infection</article-title>. <source>Lancet</source>. (<year>1961</year>) <volume>1</volume>:<fpage>313</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(61)91481-7</pub-id><?supplied-pmid 13779326?><pub-id pub-id-type="pmid">13779326</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farmer</surname><given-names>JJ</given-names><suffix>III</suffix></name><name><surname>Asbury</surname><given-names>MA</given-names></name><name><surname>Hickman</surname><given-names>FW</given-names></name><name><surname>Brenner</surname><given-names>DJ</given-names></name><collab>the Enterobacteriaceae Study Group</collab></person-group>. <article-title><italic>Enterobacter sakazakii:</italic> a new species of &#x0201c;Enterobacteriaceae&#x0201d; isolated from clinical specimens</article-title>. <source>Int J Syst Bacteriol.</source> (<year>1980</year>) <volume>30</volume>:<fpage>569</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1099/00207713-30-3-569</pub-id><?supplied-pmid 3968204?><pub-id pub-id-type="pmid">3968204</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>C</given-names></name><name><surname>Lehner</surname><given-names>A</given-names></name><name><surname>Mullane</surname><given-names>N</given-names></name><name><surname>Bidlasm</surname><given-names>E</given-names></name><name><surname>Cleenwerck</surname><given-names>I</given-names></name><name><surname>Marugg</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The taxonomy of <italic>Enterobacter sakazakii</italic>: proposal of a new genus <italic>Cronobacter</italic> gen. nov. and descriptions of <italic>Cronobacter sakazakii</italic> comb. nov. <italic>Cronobacter sakazakii</italic> subsp. <italic>sakazakii</italic>, comb. nov., <italic>Cronobacter sakazakii</italic> subsp. <italic>malonaticus</italic> subsp. nov., <italic>Cronobacter turicensis</italic> sp. nov., <italic>Cronobacter muytjensii</italic> sp. nov., <italic>Cronobacter dublinensis</italic> sp. nov. and <italic>Cronobacter</italic> genomospecies 1</article-title>. <source>BMC Evol Biol.</source> (<year>2007</year>) <volume>7</volume>:<fpage>64</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2148-7-64</pub-id><?supplied-pmid 17439656?><pub-id pub-id-type="pmid">17439656</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feeney</surname><given-names>A</given-names></name><name><surname>Kropp</surname><given-names>KA</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><name><surname>Sleator</surname><given-names>RD</given-names></name></person-group>. <article-title><italic>Cronobacter sakazakii</italic>: stress survival and virulence potential in an opportunistic foodborne pathogen</article-title>. <source>Gut Microbes.</source> (<year>2014</year>) <volume>5</volume>:<fpage>711</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.4161/19490976.2014.983774</pub-id><?supplied-pmid 25562731?><pub-id pub-id-type="pmid">25562731</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>M</given-names></name><name><surname>Fouladkhah</surname><given-names>A</given-names></name></person-group>. <article-title>Outbreak history, biofilm formation, and preventive measures for control of <italic>Cronobacter sakazakii</italic> in infant formula and infant care settings</article-title>. <source>Microorganisms.</source> (<year>2019</year>) <volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.3390/microorganisms7030077</pub-id><?supplied-pmid 30870985?><pub-id pub-id-type="pmid">30870985</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>H</given-names></name><name><surname>Gopinath</surname><given-names>GR</given-names></name><name><surname>Eshwar</surname><given-names>A</given-names></name><name><surname>Srikumar</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Gangiredla</surname><given-names>J</given-names></name></person-group>. <article-title>The secretion of toxins and other exoproteins of <italic>Cronobacter</italic>: role in virulence, adaption, and persistence</article-title>. <source>Microorganisms</source>. (<year>2020</year>) <volume>8</volume>:<fpage>229</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms8020229</pub-id><?supplied-pmid 32046365?><pub-id pub-id-type="pmid">32046365</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>B</given-names></name><name><surname>Cooney</surname><given-names>S</given-names></name><name><surname>O'Brien</surname><given-names>S</given-names></name><name><surname>Iversen</surname><given-names>C</given-names></name><name><surname>Whyte</surname><given-names>P</given-names></name><name><surname>Nally</surname><given-names>J</given-names></name><name><surname>Callanan</surname><given-names>JJ</given-names></name><name><surname>Fanning</surname><given-names>S</given-names></name></person-group>. <article-title><italic>Cronobacter</italic> (<italic>Enterobacter sakazakii</italic>): an opportunistic foodborne pathogen</article-title>. <source>Foodborne Pathog Dis.</source> (<year>2017</year>) <volume>7</volume>:<fpage>339</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2009.0379</pub-id><?supplied-pmid 19958103?><pub-id pub-id-type="pmid">19958103</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedemann</surname><given-names>M</given-names></name></person-group>. <article-title>Epidemiology of invasive neonatal <italic>Cronobacter (Enterobacter sakazakii)</italic> infections</article-title>. <source>Eur J Clin Microbiol Infect Dis.</source> (<year>2009</year>) <volume>28</volume>:<fpage>1297</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-009-0779-4</pub-id><?supplied-pmid 19662446?><pub-id pub-id-type="pmid">19662446</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>SJ</given-names></name></person-group>. <article-title>Updates on the <italic>Cronobacter</italic> genus</article-title>. <source>Annu Rev Food Sci Technol.</source> (<year>2017</year>) <volume>9</volume>:<fpage>23</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-food-030117-012246</pub-id><?supplied-pmid 29272187?><pub-id pub-id-type="pmid">29272187</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>KK</given-names></name></person-group>. <article-title><italic>Enterobacter sakazakii</italic> infections among neonates, infants, children and adults: case reports and review of the literature</article-title>. <source>Medicine</source>. (<year>2001</year>) <volume>80</volume>:<fpage>113</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1097/00005792-200103000-00004</pub-id><?supplied-pmid 11307587?><pub-id pub-id-type="pmid">11307587</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarowec-White</surname><given-names>M</given-names></name><name><surname>Farber</surname><given-names>JM</given-names></name></person-group>. <article-title><italic>Enterobacter sakazakii</italic>: a review</article-title>. <source>Int J Food Microbiol.</source> (<year>1997</year>) <volume>34</volume>:<fpage>103</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-1605(96)01172-5</pub-id><?supplied-pmid 9039558?><pub-id pub-id-type="pmid">9039558</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>BP</given-names></name><name><surname>Gelfand</surname><given-names>MS</given-names></name><name><surname>Haas</surname><given-names>M</given-names></name><name><surname>Metts</surname><given-names>L</given-names></name><name><surname>Ferguson</surname><given-names>J</given-names></name></person-group>. <article-title><italic>Enterobacter sakazakii</italic> infections in neonates associated with intrinsic contamination of a powdered infant formula</article-title>. <source>Infect Control Hosp Epidemiol.</source> (<year>1989</year>) <volume>10</volume>:<fpage>398</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1086/646060</pub-id><?supplied-pmid 2794464?><pub-id pub-id-type="pmid">2794464</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>NC</given-names></name><name><surname>Hill</surname><given-names>BC</given-names></name><name><surname>O'Hara</surname><given-names>CM</given-names></name><name><surname>Steingrimsson</surname><given-names>O</given-names></name><name><surname>Cooksey</surname><given-names>RC</given-names></name></person-group>. <article-title>Epidemiologic typing of <italic>Enterobacter sakazakii</italic> in two neonatal nosocomial outbreaks</article-title>. <source>Diagn Microbiol Infect Dis.</source> (<year>1990</year>) <volume>13</volume>:<fpage>467</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/0732-8893(90)90078-A</pub-id><?supplied-pmid 2279379?><pub-id pub-id-type="pmid">2279379</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muytjens</surname><given-names>HL</given-names></name><name><surname>Roelofs-Willemse</surname><given-names>H</given-names></name><name><surname>Jaspar</surname><given-names>GH</given-names></name></person-group>. <article-title>Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae</article-title>. <source>J Clin Microbiol.</source> (<year>1998</year>) <volume>26</volume>:<fpage>743</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.26.4.743-746.1988</pub-id><?supplied-pmid 3284901?><pub-id pub-id-type="pmid">3284901</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>C</given-names></name><name><surname>Forsythe</surname><given-names>S</given-names></name></person-group>
<article-title>Isolation of <italic>Enterobacter sakazakii</italic> and other Enterobacteriaceae from powdered infant formula milk and related products</article-title>. <source>Food Microbiol.</source> (<year>2004</year>) <volume>21</volume>:<fpage>771</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2004.01.009</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>An investigation of an acute gastroenteritis outbreak: <italic>Cronobacter sakazakii</italic>, a potential cause of food-borne illness</article-title>. <source>Front Microbiol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>2549</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.02549</pub-id><?supplied-pmid 30416493?><pub-id pub-id-type="pmid">30416493</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molloy</surname><given-names>C</given-names></name><name><surname>Cagney</surname><given-names>C</given-names></name><name><surname>Fanning</surname><given-names>S</given-names></name><name><surname>Duffy</surname><given-names>G</given-names></name></person-group>. <article-title>Survival characteristics of <italic>Cronobacter</italic> spp. in model bovine gut and in the environment</article-title>. <source>Foodborne Pathog Dis.</source> (<year>2010</year>) <volume>7</volume>:<fpage>671</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2009.0449</pub-id><?supplied-pmid 20141345?><pub-id pub-id-type="pmid">20141345</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Ling</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Lei</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Prevalence, genetic analysis and CRISPR typing of <italic>Cronobacter</italic> spp. isolated from meat and meat products in China</article-title>. <source>Int J Food Microbiol.</source> (<year>2020</year>) <volume>321</volume>:<fpage>108549</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2020.108549</pub-id><?supplied-pmid 32062304?><pub-id pub-id-type="pmid">32062304</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra-Flores</surname><given-names>J</given-names></name><name><surname>Cerda-Leal</surname><given-names>F</given-names></name><name><surname>Contreras</surname><given-names>A</given-names></name><name><surname>Valenzuela-Riffo</surname><given-names>N</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>A</given-names></name><name><surname>Aguirre</surname><given-names>J</given-names></name></person-group>. <article-title><italic>Cronobacter sakazakii</italic> and microbiological parameters in dairy formulas associated with a food alert in Chile</article-title>. <source>Front Microbiol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>1708</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.01708</pub-id><?supplied-pmid 30108565?><pub-id pub-id-type="pmid">30108565</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sani</surname><given-names>NA</given-names></name><name><surname>Odeyemi</surname><given-names>OA</given-names></name></person-group>. <article-title>Occurrence and prevalence of <italic>Cronobacter</italic> spp. in plant and animal derived food sources: a systematic review and meta-analysis</article-title>. <source>SpringerPlus.</source> (<year>2015</year>) <volume>4</volume>:<fpage>545</fpage>. <pub-id pub-id-type="doi">10.1186/s40064-015-1324-9</pub-id><?supplied-pmid 26435891?><pub-id pub-id-type="pmid">26435891</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beuchat</surname><given-names>LR</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Gurtler</surname><given-names>JB</given-names></name><name><surname>Lin</surname><given-names>LC</given-names></name><name><surname>Ryu</surname><given-names>JH</given-names></name><name><surname>Richards</surname><given-names>GM</given-names></name></person-group>. <article-title><italic>Cronobacter sakazakii</italic> in foods and factors affecting its survival, growth, and inactivation</article-title>. <source>Int J Food Microbiol.</source> (<year>2009</year>) <volume>136</volume>:<fpage>204</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.02.029</pub-id><?supplied-pmid 19346021?><pub-id pub-id-type="pmid">19346021</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandhai</surname><given-names>MC</given-names></name><name><surname>Reij</surname><given-names>MW</given-names></name><name><surname>Gorris</surname><given-names>LG</given-names></name><name><surname>Guillaume-Gentil</surname><given-names>O</given-names></name><name><surname>van Schothorst</surname><given-names>M</given-names></name></person-group>. <article-title>Occurrence of <italic>Enterobacter sakazakii</italic> in food production environments and households</article-title>. <source>Lancet.</source> (<year>2004</year>) <volume>363</volume>:<fpage>39</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(03)15169-0</pub-id><?supplied-pmid 14723994?><pub-id pub-id-type="pmid">14723994</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The occurrence and distribution characteristics of <italic>Cronobacter</italic> in diverse cereal kernels, flour, and flour-based products</article-title>. <source>Food Microbiol.</source> (<year>2019</year>) <volume>84</volume>:<fpage>103269</fpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2019.103269</pub-id><?supplied-pmid 31421791?><pub-id pub-id-type="pmid">31421791</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldonado</surname><given-names>J</given-names></name><name><surname>Gil</surname><given-names>A</given-names></name><name><surname>Narbona</surname><given-names>E</given-names></name><name><surname>Molina</surname><given-names>JA</given-names></name></person-group>
<article-title>Special formulas in infant nutrition: a review</article-title>. <source>Early Hu Dev.</source> (<year>1998</year>) <volume>53</volume>:<fpage>23</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-3782(98)00062-0</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Masum</surname><given-names>AKM</given-names></name><name><surname>Chandrapala</surname><given-names>J</given-names></name><name><surname>Huppertz</surname><given-names>T</given-names></name><name><surname>Adhikari</surname><given-names>B</given-names></name><name><surname>Zisu</surname><given-names>B</given-names></name></person-group>
<article-title>Production and characterization of infant milk formula powders: a review</article-title>. <source>Drying Technol.</source> (<year>2020</year>). <pub-id pub-id-type="doi">10.1080/07373937.2020.1767645.</pub-id> [Epub ahead of print].</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <source>Safe Preparation, Storage and Handling of Powdered Infant Formula Guidelines</source>. Geneva: World Health Organization (<year>2017</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/foodsafety/publications/powdered-infant-formula/en/">https://www.who.int/foodsafety/publications/powdered-infant-formula/en/</ext-link> (accessed October 26, 2020).<?supplied-pmid 19818006?></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>RM</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name></person-group>. <article-title>Novel approaches to improve the intrinsic microbiological safety of powdered infant milk formula</article-title>. <source>Nutrients.</source> (<year>2015</year>) <volume>7</volume>:<fpage>1217</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3390/nu7021217</pub-id><?supplied-pmid 25685987?><pub-id pub-id-type="pmid">25685987</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra-Flores</surname><given-names>J</given-names></name><name><surname>Maury-Sintjago</surname><given-names>E</given-names></name><name><surname>Rodriguez-Fern&#x000e1;ndez</surname><given-names>A</given-names></name><name><surname>Acu&#x000f1;a</surname><given-names>S</given-names></name><name><surname>Cerda</surname><given-names>F</given-names></name><name><surname>Aguirre</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Microbiological quality of powdered infant formula in Latin America</article-title>. <source>J Food Prot.</source> (<year>2020</year>) <volume>83</volume>:<fpage>534</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X.JFP-19-399</pub-id><?supplied-pmid 32078682?><pub-id pub-id-type="pmid">32078682</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname><given-names>F</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>R</given-names></name><name><surname>Von Wiese</surname><given-names>W</given-names></name></person-group>. <article-title>Klein G. Prevalence of <italic>Cronobacter</italic> spp. in a powdered infant formula processing environment</article-title>. <source>Int J Food Microbiol.</source> (<year>2010</year>) <volume>140</volume>:<fpage>214</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2010.03.031</pub-id><?supplied-pmid 20409601?><pub-id pub-id-type="pmid">20409601</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Braun</surname><given-names>P</given-names></name><name><surname>Hammer</surname><given-names>P</given-names></name></person-group>. <article-title>Reservoir and routes of transmission of <italic>Enterobacter sakazakii</italic> (<italic>Cronobacter</italic> spp</article-title>.) in a milk powder-producing plant. <source>J Dairy Sci.</source> (<year>2011</year>) <volume>94</volume>:<fpage>3801</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2011-4318</pub-id><?supplied-pmid 21787917?><pub-id pub-id-type="pmid">21787917</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Power</surname><given-names>KA</given-names></name><name><surname>Cooney</surname><given-names>S</given-names></name><name><surname>Fox</surname><given-names>E</given-names></name><name><surname>Gopinath</surname><given-names>G</given-names></name><name><surname>Grim</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>Complete genome sequence and phenotype microarray analysis of <italic>Cronobacter sakazakii</italic> SP291: a persistent isolate cultured from a powdered infant formula production facility</article-title>. <source>Front Microbiol.</source> (<year>2013</year>) <volume>4</volume>:<fpage>256</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2013.00256</pub-id><?supplied-pmid 24032028?><pub-id pub-id-type="pmid">24032028</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Lan</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Surveillance and characterisation of <italic>Cronobacter</italic> in powdered infant formula processing factories</article-title>. <source>Food Control.</source> (<year>2019</year>) <volume>96</volume>:<fpage>318</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodcont.2018.09.009</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Sha</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Matthews</surname><given-names>KR</given-names></name></person-group>. <article-title>Prevalence and genetic diversity of <italic>Cronobacter</italic> species isolated from four infant formula production factories in China</article-title>. <source>Front Microbiol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1938</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.01938</pub-id><?supplied-pmid 31497005?><pub-id pub-id-type="pmid">31497005</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurtler</surname><given-names>JB</given-names></name><name><surname>Beuchat</surname><given-names>LR</given-names></name></person-group>. <article-title>Survival of <italic>Enterobacter sakazakii</italic> in powdered infant formula as affected by composition, water activity, and temperature</article-title>. <source>J Food Prot.</source> (<year>2007</year>) <volume>70</volume>:<fpage>1579</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-70.7.1579</pub-id><?supplied-pmid 17685328?><pub-id pub-id-type="pmid">17685328</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caubilla-Barron</surname><given-names>J</given-names></name><name><surname>Forsythe</surname><given-names>S</given-names></name></person-group>. <article-title>Dry stress and survival time of <italic>Enterobacter sakazakii</italic> and other Enterobacteriaceae</article-title>. <source>J Food Prot.</source> (<year>2007</year>) <volume>70</volume>:<fpage>2111</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-70.9.2111</pub-id><?supplied-pmid 17900090?><pub-id pub-id-type="pmid">17900090</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breeuwer</surname><given-names>P</given-names></name><name><surname>Lardeau</surname><given-names>A</given-names></name><name><surname>Peterz</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>HM</given-names></name></person-group>. <article-title>Desiccation and heat tolerance of <italic>Enterobacter sakazakii</italic></article-title>. <source>J Appl Microbiol</source>. (<year>2010</year>) <volume>95</volume>:<fpage>967</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2672.2003.02067.x</pub-id><?supplied-pmid 14633024?><pub-id pub-id-type="pmid">14633024</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarowec-White</surname><given-names>M</given-names></name><name><surname>Farber</surname><given-names>JM</given-names></name></person-group>. <article-title>Thermal resistance of <italic>Enterobacter sakazakii</italic> in reconstituted dried infant formula</article-title>. <source>Lett Appl Microbiol.</source> (<year>1997</year>) <volume>24</volume>:<fpage>9</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1046/j.1472-765X.1997.00328.x</pub-id><?supplied-pmid 9023998?><pub-id pub-id-type="pmid">9023998</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osaili</surname><given-names>TM</given-names></name><name><surname>Shaker</surname><given-names>RR</given-names></name><name><surname>Al-Haddaq</surname><given-names>MS</given-names></name><name><surname>Al-Nabulsi</surname><given-names>AA</given-names></name><name><surname>Holley</surname><given-names>RA</given-names></name></person-group>. <article-title>Heat resistance of <italic>Cronobacter</italic> species (<italic>Enterobacter sakazakii</italic>) in milk and special feeding formula</article-title>. <source>J Appl Microbiol.</source> (<year>1989</year>) <volume>107</volume>:<fpage>928</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2672.2009.04271.x</pub-id><?supplied-pmid 19320941?><pub-id pub-id-type="pmid">19320941</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyo</surname><given-names>C</given-names></name><name><surname>Condon</surname><given-names>S</given-names></name><name><surname>Pagan</surname><given-names>R</given-names></name></person-group>. <article-title>Thermobacteriological characterization of <italic>Enterobacter sakazakii</italic></article-title>. <source>Int J Food Microbiol</source>. (<year>2009</year>) <volume>136</volume>:<fpage>110</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.09.013</pub-id><?supplied-pmid 19811846?><pub-id pub-id-type="pmid">19811846</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arku</surname><given-names>B</given-names></name><name><surname>Fanning</surname><given-names>S</given-names></name><name><surname>Jordan</surname><given-names>K</given-names></name></person-group>. <article-title>Heat adaptation and survival of <italic>Cronobacter</italic> spp</article-title>. (formerly <italic>Enterobacter sakazakii</italic>). <source>Foodborne Pathog Dis.</source> (<year>2011</year>) <volume>8</volume>:<fpage>975</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2010.0819</pub-id><?supplied-pmid 21542776?><pub-id pub-id-type="pmid">21542776</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huertas</surname><given-names>JP</given-names></name><name><surname>&#x000c1;lvarez-Ord&#x000f3;&#x000f1;ez</surname><given-names>A</given-names></name><name><surname>Morrissey</surname><given-names>R</given-names></name><name><surname>Ros-Chumillas</surname><given-names>M</given-names></name><name><surname>Esteban</surname><given-names>MD</given-names></name><name><surname>Mat&#x000e9;</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Heat resistance of <italic>Cronobacter sakazakii</italic> DPC 6529 and its behavior in reconstituted powdered infant formula</article-title>. <source>Food Res Int.</source> (<year>2015</year>) <volume>69</volume>:<fpage>401</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2015.01.010</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>
<source>WHO/FAO Guidelines for the Safe Preparation, Storage and Handling of Powdered Infant Formula</source>. (<year>2006</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.ennonline.net/infantformulaguidelines">www.ennonline.net/infantformulaguidelines</ext-link> (accessed October 26, 2020).</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osaili</surname><given-names>TM</given-names></name><name><surname>Al-Nabulsi</surname><given-names>AA</given-names></name><name><surname>Shaker</surname><given-names>RR</given-names></name><name><surname>Ayyash</surname><given-names>MM</given-names></name><name><surname>Olaimat</surname><given-names>AN</given-names></name><name><surname>Abu</surname><given-names>Al-Hasan AS</given-names></name><etal/></person-group>. <article-title>Effects of extended dry storage of powdered infant milk formula on susceptibility of <italic>Enterobacter sakazakii</italic> to hot water and ionizing irradiation</article-title>. <source>J Food Prot.</source> (<year>2008</year>) <volume>71</volume>:<fpage>934</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-71.5.934</pub-id><?supplied-pmid 18522026?><pub-id pub-id-type="pmid">18522026</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turck</surname><given-names>D</given-names></name></person-group>. <article-title>Safety aspects in preparation and handling of infant food</article-title>. <source>Ann Nutr Metab.</source> (<year>2012</year>) <volume>60</volume>:<fpage>211</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1159/000338215</pub-id><?supplied-pmid 22699771?><pub-id pub-id-type="pmid">22699771</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>TJ</given-names></name><name><surname>Hwang</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>HW</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kwon</surname><given-names>JI</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><etal/></person-group>. <article-title>Underestimated risks of infantile infectious disease from the caregiver's typical handling practices of infant formula</article-title>. <source>Sci Rep.</source> (<year>2019</year>) <volume>9</volume>:<fpage>9799</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-46181-0</pub-id><?supplied-pmid 31278304?><pub-id pub-id-type="pmid">31278304</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>C</given-names></name><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Forsythe</surname><given-names>SJ</given-names></name></person-group>. <article-title>The growth profile, thermotolerance and biofilm formation of <italic>Enterobacter sakazakii</italic> grown in infant formula milk</article-title>. <source>Lett Appl Microbiol.</source> (<year>2004</year>) <volume>38</volume>:<fpage>378</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.2004.01507.x</pub-id><?supplied-pmid 15059207?><pub-id pub-id-type="pmid">15059207</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehner</surname><given-names>A</given-names></name><name><surname>Riedel</surname><given-names>K</given-names></name><name><surname>Eberl</surname><given-names>L</given-names></name><name><surname>Breeuwer</surname><given-names>P</given-names></name><name><surname>Diep</surname><given-names>B</given-names></name></person-group>
<article-title>Biofilm formation, extracellular polysaccharide production, and cell-to-cell signaling in various <italic>Enterobacter sakazakii</italic> strains: aspects promoting environmental persistence</article-title>. <source>J Food Prot.</source> (<year>2005</year>) <volume>6</volume>:<fpage>2287</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-68.11.2287</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurrell</surname><given-names>E</given-names></name><name><surname>Kucerova</surname><given-names>E</given-names></name><name><surname>Loughlin</surname><given-names>M</given-names></name><name><surname>Caubilla-Barron</surname><given-names>J</given-names></name><name><surname>Forsythe</surname><given-names>SJ</given-names></name></person-group>. <article-title>Biofilm formation on enteral feeding tubes by <italic>Cronobacter sakazakii, Salmonella</italic> serovars and other Enterobacteriaceae</article-title>. <source>Int J Food Microbiol.</source> (<year>2009</year>) <volume>136</volume>:<fpage>227</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.08.007</pub-id><?supplied-pmid 19720416?><pub-id pub-id-type="pmid">19720416</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>N</given-names></name><name><surname>Forsythe</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group>
<article-title>Insights into <italic>Cronobacter sakazakii</italic> biofilm formation and control strategies in the food industry</article-title>. <source>Engineering.</source> (<year>2020</year>) <volume>6</volume>:<fpage>393</fpage>&#x02013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/j.eng.2020.02.007</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pina-P&#x000e9;rez</surname><given-names>MC</given-names></name><name><surname>Rodrigo</surname><given-names>D</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>A</given-names></name></person-group>. <article-title>Nonthermal inactivation of <italic>Cronobacter sakazakii</italic> in infant formula milk: a review</article-title>. <source>Crit Rev Food Sci Nutr.</source> (<year>2016</year>) <volume>56</volume>:<fpage>1620</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2013.781991</pub-id><?supplied-pmid 25603362?><pub-id pub-id-type="pmid">25603362</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahern</surname><given-names>GJ</given-names></name><name><surname>Hennessy</surname><given-names>AA</given-names></name><name><surname>Ryan</surname><given-names>CA</given-names></name><name><surname>Ross</surname><given-names>R</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name></person-group>. <article-title>Advances in infant formula science</article-title>. <source>Ann Rev Food Sci Technol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>75</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-food-081318-104308</pub-id><?supplied-pmid 30908947?><pub-id pub-id-type="pmid">30908947</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname><given-names>S</given-names></name><name><surname>Sanchez-Siles</surname><given-names>LM</given-names></name><name><surname>Siegrist</surname><given-names>M</given-names></name></person-group>
<article-title>The importance of food naturalness for consumers: results of a systematic review</article-title>. <source>Trends Food Sci Technol.</source> (<year>2017</year>) <volume>67</volume>:<fpage>44</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.tifs.2017.06.010</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurtler</surname><given-names>JB</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>T</given-names></name><name><surname>Niemira</surname><given-names>BA</given-names></name></person-group>. <article-title>Influence of antimicrobial agents on the thermal sensitivity of foodborne pathogens: a review</article-title>. <source>J Food Prot.</source> (<year>2019</year>) <volume>82</volume>:<fpage>628</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X.JFP-18-441</pub-id><?supplied-pmid 30917037?><pub-id pub-id-type="pmid">30917037</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinto</surname><given-names>EJ</given-names></name><name><surname>Caro</surname><given-names>I</given-names></name><name><surname>Villalobos-Delgado</surname><given-names>LH</given-names></name><name><surname>Mateo</surname><given-names>J</given-names></name><name><surname>De-Mateo-Silleras</surname><given-names>B</given-names></name><name><surname>Redondo-Del-R&#x000ed;o</surname><given-names>MP</given-names></name></person-group>. <article-title>Food safety through natural antimicrobials</article-title>. <source>Antibiotics</source>. (<year>2019</year>) <volume>8</volume>:<fpage>208</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics8040208</pub-id><?supplied-pmid 31683578?><pub-id pub-id-type="pmid">31683578</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajkarimi</surname><given-names>M</given-names></name><name><surname>Ibrahim</surname><given-names>S</given-names></name><name><surname>Cliver</surname><given-names>D</given-names></name></person-group>
<article-title>Antimicrobial herb and spice compounds in food</article-title>. <source>Food Control.</source> (<year>2010</year>) <volume>21</volume>:<fpage>1199</fpage>
<pub-id pub-id-type="doi">10.1016/j.foodcont.2010.02.003</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>JL</given-names></name><name><surname>Weng</surname><given-names>WL</given-names></name><name><surname>Chen</surname><given-names>WW</given-names></name><name><surname>Corbitt</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>YS</given-names></name><name><surname>Chen</surname><given-names>YS</given-names></name></person-group>. <article-title>Inactivation of <italic>Enterobacter sakazakii</italic> by water-soluble muscadine seed extracts</article-title>. <source>Int J Food Microbiol.</source> (<year>2009</year>) <volume>129</volume>:<fpage>3295</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.12.014</pub-id><?supplied-pmid 19167124?><pub-id pub-id-type="pmid">19167124</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TJ</given-names></name><name><surname>Weng</surname><given-names>WL</given-names></name><name><surname>Silva</surname><given-names>JL</given-names></name><name><surname>Jung</surname><given-names>YS</given-names></name><name><surname>Marshall</surname><given-names>D</given-names></name></person-group>. <article-title>Identification of natural antimicrobial substances in red muscadine juice against <italic>Cronobacter sakazakii</italic></article-title>. <source>J Food Sci</source>. (<year>2010</year>) <volume>75</volume>:<fpage>150</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3841.2010.01531.x</pub-id><?supplied-pmid 20492304?><pub-id pub-id-type="pmid">20492304</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pina-P&#x000e9;rez</surname><given-names>MC</given-names></name><name><surname>Rodrigo</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name></person-group>
<article-title>Bacteriostatic effect of cocoa powder rich in polyphenols to control <italic>Cronobacter sakazakii</italic> proliferation in infant milk formula</article-title>. Science and Technology against Microbial Pathogens. Research, Development and Evaluation. In: <source>Proceedings of the International Conference on Antimicrobial research (ICAR 2010)</source>. <publisher-loc>Valladolid</publisher-loc>: <publisher-name>World Scientific Publishing Co. Pte. Ltd</publisher-name> (<year>2010</year>). p. <fpage>85</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>SS</given-names></name><name><surname>Howell</surname><given-names>AB</given-names></name><name><surname>D'Souza</surname><given-names>DH</given-names></name></person-group>. <article-title><italic>Cronobacter sakazakii</italic> reduction by blueberry proanthocyanidins</article-title>. <source>Food Microbiol.</source> (<year>2014</year>) <volume>39</volume>:<fpage>127</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2013.11.002</pub-id><?supplied-pmid 24387862?><pub-id pub-id-type="pmid">24387862</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Patil</surname><given-names>A</given-names></name><name><surname>Prabhune</surname><given-names>A</given-names></name><name><surname>Goel</surname><given-names>G</given-names></name></person-group>. <article-title>Inhibition of quorum-sensing mediated biofilm formation in <italic>Cronobacter sakazakii</italic> strains</article-title>. <source>Microbiology.</source> (<year>2016</year>) <volume>162</volume>:<fpage>1708</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.000342</pub-id><?supplied-pmid 27460095?><pub-id pub-id-type="pmid">27460095</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Man</surname><given-names>CX</given-names></name><name><surname>Lou</surname><given-names>BB</given-names></name><name><surname>Niu</surname><given-names>JT</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Tea polyphenols inactivate <italic>Cronobacter sakazakii</italic> isolated from powdered infant formula</article-title>. <source>J Dairy Sci.</source> (<year>2016</year>) <volume>99</volume>:<fpage>1019</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2015-10039</pub-id><?supplied-pmid 26627860?><pub-id pub-id-type="pmid">26627860</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Ali</surname><given-names>MA</given-names></name><name><surname>Gong</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Bi</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Antimicrobial activity and mechanism of action of olive oil polyphenols extract against <italic>Cronobacter sakazakii</italic></article-title>. <source>Food Control</source>. (<year>2018</year>) <volume>94</volume>:<fpage>289</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodcont.2018.07.022</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polat</surname><given-names>Yemi&#x0015f; G</given-names></name><name><surname>Bach</surname><given-names>S</given-names></name><name><surname>Delaquis</surname><given-names>P</given-names></name></person-group>
<article-title>Antibacterial activity of polyphenol-rich pomegranate peel extract against <italic>Cronobacter sakazakii</italic></article-title>. <source>Int J Food Prop</source>. (<year>2019</year>) <volume>22</volume>:<fpage>985</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1080/10942912.2019.1622564</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankov&#x000e1;</surname><given-names>A</given-names></name><name><surname>Marounek</surname><given-names>M</given-names></name><name><surname>Mozrov&#x000e1;</surname><given-names>V</given-names></name><name><surname>Weber</surname><given-names>J</given-names></name><name><surname>Klou&#x0010d;ek</surname><given-names>P</given-names></name><name><surname>Luke&#x00161;ov&#x000e1;</surname><given-names>D</given-names></name></person-group>. <article-title>Antibacterial activities of plant-derived compounds and essential oils toward <italic>Cronobacter sakazakii</italic> and <italic>Cronobacter malonaticus</italic></article-title>. <source>Foodborne Pathog Dis</source>. (<year>2014</year>). <volume>11</volume>:<fpage>795</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2014.1737</pub-id><?supplied-pmid 25062020?><pub-id pub-id-type="pmid">25062020</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Nabulsi</surname><given-names>AA</given-names></name><name><surname>Awaisheh</surname><given-names>SS</given-names></name><name><surname>Osaili</surname><given-names>TM</given-names></name><name><surname>Olaimat</surname><given-names>AN</given-names></name><name><surname>Rahahaleh</surname><given-names>RJ</given-names></name><name><surname>Al-Dabbas</surname><given-names>FM</given-names></name><etal/></person-group>
<article-title>Inactivation of <italic>Cronobacter sakazakii</italic> in reconstituted infant milk formula by plant essential oils</article-title>. <source>J Appl Bot Food Qual.</source> (<year>2015</year>) <volume>88</volume>:<fpage>97</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.5073/JABFQ.2015.088.013</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Ghazaleh</surname><given-names>BM</given-names></name></person-group>
<article-title>Antimicrobial activity of <italic>Thymus vulgaris</italic> extract, <italic>Syzygium aromaticum</italic> extract and <italic>Zingiber officinale</italic> extract on <italic>Cronobacter</italic> spp. as compared with common preservatives</article-title>. <source>Pharmacologyonline Arch.</source> (<year>2019</year>) <volume>2</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthold-Pluta</surname><given-names>A</given-names></name><name><surname>Stasiak-R&#x000f3;za&#x00144;ska</surname><given-names>L</given-names></name><name><surname>Pluta</surname><given-names>A</given-names></name><name><surname>Garbowska</surname><given-names>M</given-names></name></person-group>
<article-title>Antibacterial activities of plant-derived compounds and essential oils against <italic>Cronobacter strains</italic></article-title>. <source>Eur Food Res Technol</source>. (<year>2019</year>) <volume>245</volume>:<fpage>1137</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/s00217-018-3218-x</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Jin</surname><given-names>HH</given-names></name></person-group>. <article-title>Inhibitory activity of natural antimicrobial compounds alone or in combination with nisin against <italic>Enterobacter sakazakii</italic></article-title>. <source>Lett Appl Microbiol</source>. (<year>2008</year>) <volume>47</volume>:<fpage>315</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.2008.02432.x</pub-id><?supplied-pmid 19241526?><pub-id pub-id-type="pmid">19241526</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amalaradjou</surname><given-names>MA</given-names></name><name><surname>Hoagland</surname><given-names>TA</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K</given-names></name></person-group>. <article-title>Inactivation of <italic>Enterobacter sakazakii</italic> in reconstituted infant formula by trans-cinnamaldehyde</article-title>. <source>Int J Food Microbiol.</source> (<year>2009</year>) <volume>129</volume>:<fpage>146</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.11.016</pub-id><?supplied-pmid 19091435?><pub-id pub-id-type="pmid">19091435</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amalaradjou</surname><given-names>MAR</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K</given-names></name></person-group>. <article-title>Effect of trans-cinnamaldehyde on reducing resistance to environmental stresses in <italic>Cronobacter sakazakii</italic></article-title>. <source>Foodborne Pathog Dis</source>. (<year>2011</year>) <volume>8</volume>:<fpage>403</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2010.0691</pub-id><?supplied-pmid 21114424?><pub-id pub-id-type="pmid">21114424</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polat Yemi&#x0015f;</surname><given-names>GP</given-names></name><name><surname>Pagotto</surname><given-names>F</given-names></name><name><surname>Bach</surname><given-names>S</given-names></name><name><surname>Delaquis</surname><given-names>P</given-names></name></person-group>. <article-title>Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of <italic>Cronobacter</italic> species</article-title>. <source>J Food Prot</source>. (<year>2011</year>) <volume>74</volume>:<fpage>2062</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X.JFP-11-230</pub-id><?supplied-pmid 22186046?><pub-id pub-id-type="pmid">22186046</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polat</surname><given-names>Yemi&#x0015f; GP</given-names></name><name><surname>Pagotto</surname><given-names>F</given-names></name><name><surname>Bach</surname><given-names>S</given-names></name><name><surname>Delaquis</surname><given-names>P</given-names></name></person-group>. <article-title>Thermal tolerance and survival of <italic>Cronobacter sakazakii</italic> in powdered infant formula supplemented with vanillin, ethyl vanillin, and vanillic acid</article-title>. <source>J Food Sci.</source> (<year>2012</year>) <volume>77</volume>:<fpage>523</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3841.2012.02834.x</pub-id><?supplied-pmid 22900597?><pub-id pub-id-type="pmid">22900597</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>HI</given-names></name><name><surname>Rhee</surname><given-names>MS</given-names></name></person-group>. <article-title>Inhibitory effect of caprylic acid and mild heat on <italic>Cronobacter</italic> spp. (<italic>Enterobacter sakazakii</italic>) in reconstituted infant formula and determination of injury by flow cytometry</article-title>. <source>Int J Food Microbiol.</source> (<year>2009</year>) <volume>133</volume>:<fpage>113</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.05.009</pub-id><?supplied-pmid 19500867?><pub-id pub-id-type="pmid">19500867</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>NY</given-names></name><name><surname>Rhee</surname><given-names>MS</given-names></name></person-group>. <article-title>New decontamination method based on caprylic acid in combination with citric acid or vanillin for eliminating <italic>Cronobacter sakazakii</italic> and <italic>Salmonella enterica</italic> serovar Typhimurium in reconstituted infant formula</article-title>. <source>Int J Food Microbiol</source>. (<year>2013</year>). <volume>166</volume>:<fpage>499</fpage>&#x02013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2013.08.016</pub-id><?supplied-pmid 24042002?><pub-id pub-id-type="pmid">24042002</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Sui</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Antimicrobial activity and possible mechanism of action of citral against <italic>Cronobacter sakazakii</italic></article-title>. <source>PLoS ONE</source>. (<year>2016</year>) <volume>11</volume>:<fpage>e0159006</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0159006</pub-id><?supplied-pmid 27415761?><pub-id pub-id-type="pmid">27415761</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Antimicrobial activity of syringic acid against <italic>Cronobacter sakazakii</italic> and its effect on cell membrane</article-title>. <source>Food Chem.</source> (<year>2016</year>) <volume>197</volume>:<fpage>100</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2015.10.100</pub-id><?supplied-pmid 26616929?><pub-id pub-id-type="pmid">26616929</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Antimicrobial activity of ferulic acid against <italic>Cronobacter sakazakii</italic> and possible mechanism of action</article-title>. <source>Foodborne Pathog Dis.</source> (<year>2016</year>) <volume>13</volume>:<fpage>196</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2015.1992</pub-id><?supplied-pmid 26919471?><pub-id pub-id-type="pmid">26919471</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Inactivation of <italic>Cronobacter sakazakii</italic> in reconstituted infant formula by combination of thymoquinone and mild heat</article-title>. <source>J Appl Microbiol.</source> (<year>2015</year>) <volume>119</volume>:<fpage>1700</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/jam.12964</pub-id><?supplied-pmid 26440735?><pub-id pub-id-type="pmid">26440735</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Sui</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Thymoquinone inhibits virulence related traits of Cro<italic>nobacter sakazakii</italic> ATCC 29544 and has anti-biofilm formation potential</article-title>. <source>Front Microbiol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>2220</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02220</pub-id><?supplied-pmid 29234307?><pub-id pub-id-type="pmid">29234307</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Effect of thymoquinone on the resistance of <italic>Cronobacter sakazakii</italic> to environmental stresses and antibiotics</article-title>. <source>Food Control.</source> (<year>2020</year>) <volume>109</volume>:<fpage>106944</fpage>
<pub-id pub-id-type="doi">10.1016/j.foodcont.2019.106944</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Zhoua</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Yua</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>
<article-title><italic>Cronobacter sakazakii</italic> CICC 21544 responds to the combination of carvacrol and citral by regulating proton motive force</article-title>. <source>LWT Food Sci Technol.</source> (<year>2020</year>) <volume>122</volume>:<fpage>109040</fpage>
<pub-id pub-id-type="doi">10.1016/j.lwt.2020.109040</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>The antimicrobial activity of coenzyme Q<sub>0</sub> against planktonic and biofilm forms of <italic>Cronobacter sakazakii</italic></article-title>. <source>Food Microbiol</source>. (<year>2020</year>) <volume>86</volume>:<fpage>103337</fpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2019.103337</pub-id><?supplied-pmid 31703870?><pub-id pub-id-type="pmid">31703870</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouarab-Chibane</surname><given-names>L</given-names></name><name><surname>Forquet</surname><given-names>V</given-names></name><name><surname>Lant&#x000e9;ri</surname><given-names>P</given-names></name><name><surname>Cl&#x000e9;ment</surname><given-names>Y</given-names></name><name><surname>L&#x000e9;onard-Akkari</surname><given-names>L</given-names></name><name><surname>Oulahal</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Antibacterial properties of polyphenols: characterization and QSAR (Quantitative Structure-Activity Relationship) models</article-title>. <source>Front Microbiol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>829</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00829</pub-id><?supplied-pmid 31057527?><pub-id pub-id-type="pmid">31057527</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turek</surname><given-names>C</given-names></name><name><surname>Stintzing</surname><given-names>FC</given-names></name></person-group>
<article-title>Stability of essential oils: a review</article-title>. <source>Compr Rev Food Sci Food Saf.</source> (<year>2013</year>) <volume>12</volume>:<fpage>40</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/1541-4337.12006</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>McClements</surname><given-names>DJ</given-names></name></person-group>. <article-title>Improving the efficacy of essential oils as antimicrobials in foods: mechanisms of action</article-title>. <source>Annu Rev Food Sci Technol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>365</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-food-032818-121727</pub-id><?supplied-pmid 30653350?><pub-id pub-id-type="pmid">30653350</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>C</given-names></name><name><surname>Bouquillon</surname><given-names>S</given-names></name><name><surname>Fauconnier</surname><given-names>ML</given-names></name></person-group>. <article-title>Encapsulation of essential oils for the development of biosourced pesticides with controlled release: a review</article-title>. <source>Molecules.</source> (<year>2019</year>) <volume>24</volume>:<fpage>2539</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24142539</pub-id><?supplied-pmid 31336803?><pub-id pub-id-type="pmid">31336803</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>M</given-names></name><name><surname>Barrett</surname><given-names>E</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name></person-group>. <article-title>Evaluation of an antimicrobial ingredient prepared from a <italic>Lactobacillus acidophilus</italic> casein fermentate against <italic>Enterobacter sakazakii</italic></article-title>. <source>J Food Prot</source>. (<year>2009</year>) <volume>72</volume>:<fpage>340</fpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-72.2.340</pub-id><?supplied-pmid 19350978?><pub-id pub-id-type="pmid">19350978</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awaisheh</surname><given-names>SS</given-names></name><name><surname>Al-Nabulsi</surname><given-names>AA</given-names></name><name><surname>Osaili</surname><given-names>TM</given-names></name><name><surname>Ibrahim</surname><given-names>S</given-names></name><name><surname>Holley</surname><given-names>R</given-names></name></person-group>. <article-title>Inhibition of <italic>Cronobacter sakazakii</italic> by heat labile bacteriocins produced by probiotic LAB isolated from healthy infants</article-title>. <source>J Food Sci.</source> (<year>2013</year>) <volume>78</volume>:<fpage>1416</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/1750-3841.12209</pub-id><?supplied-pmid 23924352?><pub-id pub-id-type="pmid">23924352</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charchoghlyan</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>H</given-names></name><name><surname>Hwang</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name></person-group>. <article-title>Inhibition of <italic>Cronobacter sakazakii</italic> by <italic>Lactobacillus acidophilus</italic> n.v. Er2 317/402</article-title>. <source>Korean J Food Sci Anim Resour.</source> (<year>2016</year>) <volume>36</volume>:<fpage>635</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.5851/kosfa.2016.36.5.635</pub-id><?supplied-pmid 27857539?><pub-id pub-id-type="pmid">27857539</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Jeong</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>KY</given-names></name><name><surname>Kang</surname><given-names>IB</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Seo</surname><given-names>KH</given-names></name></person-group>. <article-title>Culture supernatant produced by <italic>Lactobacillus kefiri</italic> from kefir inhibits the growth of <italic>Cronobacter sakazakii</italic></article-title>. <source>J Dairy Res</source>. (<year>2018</year>) <volume>85</volume>:<fpage>98</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1017/S0022029917000802</pub-id><?supplied-pmid 29468996?><pub-id pub-id-type="pmid">29468996</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campana</surname><given-names>R</given-names></name><name><surname>Federici</surname><given-names>S</given-names></name><name><surname>Ciandrini</surname><given-names>E</given-names></name><name><surname>Mani</surname><given-names>A</given-names></name><name><surname>Buffone</surname><given-names>W</given-names></name></person-group>. <article-title><italic>Lactobacillus</italic> spp. inhibit the growth of <italic>Cronobacter sakazakii</italic> ATCC 29544 by altering its membrane integrity</article-title>. <source>J Food Sci Technol.</source> (<year>2019</year>) <volume>56</volume>:<fpage>3962</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s13197-019-03928-x</pub-id><?supplied-pmid 31413422?><pub-id pub-id-type="pmid">31413422</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campion</surname><given-names>A</given-names></name><name><surname>Morrissey</surname><given-names>R</given-names></name><name><surname>Field</surname><given-names>D</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name></person-group>. <article-title>Use of enhanced nisin derivatives in combination with food-grade oils or citric acid to control <italic>Cronobacter sakazakii</italic> and <italic>Escherichia coli</italic> O157: H7</article-title>. <source>Food Microbiol.</source> (<year>2017</year>) <volume>65</volume>:<fpage>254</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2017.01.020</pub-id><?supplied-pmid 28400011?><pub-id pub-id-type="pmid">28400011</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Isolauri</surname><given-names>E</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name></person-group>. <article-title>Specific probiotic strains and their combinations counteract adhesion of <italic>Enterobacter sakazakii</italic> to intestinal mucus</article-title>. <source>FEMS Microbiol Lett.</source> (<year>2008</year>) <volume>285</volume>:<fpage>58</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2008.01211.x</pub-id><?supplied-pmid 18503543?><pub-id pub-id-type="pmid">18503543</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapourchali</surname><given-names>FR</given-names></name><name><surname>Cresci</surname><given-names>GAM</given-names></name></person-group>. <article-title>Early-life gut microbiome-the importance of maternal and infant factors in its establishment</article-title>. <source>Nutr Clin Pract</source>. (<year>2020</year>) <volume>35</volume>:<fpage>386</fpage>&#x02013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1002/ncp.10490</pub-id><?supplied-pmid 32329544?><pub-id pub-id-type="pmid">32329544</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro-Tapia</surname><given-names>E</given-names></name><name><surname>Sebastiani</surname><given-names>G</given-names></name><name><surname>Sailer</surname></name><name><surname>S</surname><given-names>Almeida</given-names></name><name><surname>Toledano</surname><given-names>L</given-names></name><name><surname>Serra-Delgado</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Probiotic supplementation during the perinatal and infant period: effects on gut dysbiosis and disease</article-title>. <source>Nutrients.</source> (<year>2020</year>) <volume>12</volume>:<fpage>2243</fpage>. <pub-id pub-id-type="doi">10.3390/nu12082243</pub-id><?supplied-pmid 32727119?><pub-id pub-id-type="pmid">32727119</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>G</given-names></name><name><surname>Athalye-Jape</surname><given-names>G</given-names></name><name><surname>Patole</surname><given-names>S</given-names></name></person-group>. <article-title>Para-probiotics for preterm neonates - the next frontier</article-title>. <source>Nutrients.</source> (<year>2018</year>)<volume>10</volume>:<fpage>871</fpage>. <pub-id pub-id-type="doi">10.3390/nu10070871</pub-id><?supplied-pmid 29976885?><pub-id pub-id-type="pmid">29976885</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Toal&#x000e1;</surname><given-names>JE</given-names></name><name><surname>Garcia-Varela</surname><given-names>R</given-names></name><name><surname>Garcia</surname><given-names>HS</given-names></name><name><surname>Mata-Haro</surname><given-names>V</given-names></name><name><surname>Gonz&#x000e1;lez-C&#x000f3;rdova</surname><given-names>AF</given-names></name><name><surname>Vallejo-Cordoba</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Postbiotics: an evolving term within the functional foods field</article-title>. <source>Trends Food Sci Technol.</source> (<year>2018</year>) <volume>75</volume>:<fpage>105</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.tifs.2018.03.009</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarra-S&#x000e1;nchez</surname><given-names>LA</given-names></name><name><surname>El-Haddad</surname><given-names>N</given-names></name><name><surname>Mahmoud</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>MJ</given-names></name><name><surname>Karam</surname><given-names>L</given-names></name></person-group>. <article-title>Invited review: advances in nisin use for preservation of dairy products</article-title>. <source>J Dairy Sci</source>. (<year>2020</year>) <volume>103</volume>:<fpage>2041</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2019-17498</pub-id><?supplied-pmid 31928749?><pub-id pub-id-type="pmid">31928749</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Nabulsi</surname><given-names>A</given-names></name><name><surname>Osaili</surname><given-names>TM</given-names></name><name><surname>Al-Holy</surname><given-names>MA</given-names></name><name><surname>Shaker</surname><given-names>RR</given-names></name><name><surname>Ayyash</surname><given-names>MM</given-names></name><name><surname>Olaimat</surname><given-names>AN</given-names></name><name><surname>Holley</surname><given-names>RA</given-names></name></person-group>. <article-title>Influence of desiccation on the sensitivity of <italic>Cronobacter</italic> spp. to lactoferrin or nisin in broth and powdered infant formula</article-title>. <source>Int J Food Microbiol.</source> (<year>2009</year>) <volume>136</volume>:<fpage>221</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.08.008</pub-id><?supplied-pmid 19720412?><pub-id pub-id-type="pmid">19720412</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>PM</given-names></name><name><surname>Kuniyoshi</surname><given-names>TM</given-names></name><name><surname>Oliveira</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name></person-group>. <article-title>Antimicrobials for food and feed; a bacteriocin perspective</article-title>. <source>Curr Opin Biotechnol.</source> (<year>2020</year>) <volume>61</volume>:<fpage>160</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2019.12.023</pub-id><?supplied-pmid 31968296?><pub-id pub-id-type="pmid">31968296</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurtler</surname><given-names>JB</given-names></name><name><surname>Beuchat</surname><given-names>LR</given-names></name></person-group>. <article-title>Inhibition of growth of <italic>Enterobacter sakazakii</italic> in reconstituted infant formula by the lactoperoxidase system</article-title>. <source>J Food Prot.</source> (<year>2007</year>) <volume>70</volume>:<fpage>2104</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-70.9.2104</pub-id><?supplied-pmid 17900089?><pub-id pub-id-type="pmid">17900089</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harouna</surname><given-names>S</given-names></name><name><surname>Carrami&#x000f1;ana</surname><given-names>JJ</given-names></name><name><surname>Navarro</surname><given-names>F</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>MD</given-names></name><name><surname>Calvo</surname><given-names>M</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>L</given-names></name></person-group>
<article-title>Antibacterial activity of bovine milk lactoferrin on the emerging foodborne pathogen <italic>Cronobacter sakazakii</italic>: effect of media and heat treatment</article-title>. <source>Food Control.</source> (<year>2015</year>) <volume>47</volume>:<fpage>520</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodcont.2014.07.061</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harouna</surname><given-names>S</given-names></name><name><surname>Franco</surname><given-names>I</given-names></name><name><surname>Carrami&#x000f1;ana</surname><given-names>JJ</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>A</given-names></name><name><surname>Abad</surname><given-names>I</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>MD</given-names></name><etal/></person-group>. <article-title>Effect of hydrolysis and microwave treatment on the antibacterial activity of native bovine milk lactoferrin against <italic>Cronobacter sakazakii</italic></article-title>. <source>Int J Food Microbiol</source>. (<year>2020</year>) <volume>319</volume>:<fpage>108495</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2019.108495</pub-id><?supplied-pmid 31911211?><pub-id pub-id-type="pmid">31911211</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T&#x000e9;n&#x000e9;</surname><given-names>N</given-names></name><name><surname>Roche-Chatain</surname><given-names>V</given-names></name><name><surname>Rifflet</surname><given-names>A</given-names></name><name><surname>Bonnafe</surname><given-names>E</given-names></name><name><surname>Lefranc</surname><given-names>B</given-names></name><name><surname>Leprince</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Potent bactericidal effects of bicarinalin against strains of the <italic>Enterobacter</italic> and <italic>Cronobacter</italic> genera</article-title>. <source>Food Control.</source> (<year>2014</year>) <volume>42</volume>:<fpage>202</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodcont.2014.02.026</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abusheliabi</surname><given-names>A</given-names></name><name><surname>Al-Rumaithi</surname><given-names>HO</given-names></name><name><surname>Olaimat</surname><given-names>AN</given-names></name><name><surname>Al-Nabulsi</surname><given-names>AA</given-names></name><name><surname>Osaili</surname><given-names>T</given-names></name><name><surname>Shaker</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Inhibitory effect of camel milk on <italic>Cronobacter sakazakii</italic></article-title>. <source>J Food Saf</source>. (<year>2017</year>) <volume>37</volume>:<fpage>e12343</fpage>
<pub-id pub-id-type="doi">10.1111/jfs.12343</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willemin</surname><given-names>ME</given-names></name><name><surname>Lumen</surname><given-names>A</given-names></name></person-group>. <article-title>Thiocyanate: a review and evaluation of the kinetics and the modes of action for thyroid hormone perturbations</article-title>. <source>Crit Rev Toxicol.</source> (<year>2017</year>) <volume>47</volume>:<fpage>537</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1080/10408444.2017.1281590</pub-id><?supplied-pmid 28632039?><pub-id pub-id-type="pmid">28632039</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellison</surname><given-names>RT</given-names></name><name><surname>Giehl</surname><given-names>TJ</given-names></name><name><surname>LaForce</surname><given-names>FM</given-names></name></person-group>. <article-title>Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin</article-title>. <source>Infect Immunol.</source> (<year>1988</year>) <volume>56</volume>:<fpage>2774</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.56.11.2774-2781.1988</pub-id><?supplied-pmid 3169987?><pub-id pub-id-type="pmid">3169987</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kell</surname><given-names>DB</given-names></name><name><surname>Heyden</surname><given-names>EL</given-names></name><name><surname>Pretorius</surname><given-names>E</given-names></name></person-group>. <article-title>The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria</article-title>. <source>Front Immunol.</source> (<year>2020</year>)<volume>11</volume>:<fpage>1221</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2020.01221</pub-id><?supplied-pmid 32574271?><pub-id pub-id-type="pmid">32574271</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Pan</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Enteral lactoferrin supplementation for preventing sepsis and necrotizing enterocolitis in preterm infants: a meta analysis with trial sequential analysis of randomized controlled trials</article-title>. <source>Front Pharmacol.</source> (<year>2020</year>) <volume>11</volume>:<fpage>1186</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.01186</pub-id><?supplied-pmid 32848789?><pub-id pub-id-type="pmid">32848789</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoek</surname><given-names>KS</given-names></name><name><surname>Milne</surname><given-names>J</given-names></name><name><surname>Grieve</surname><given-names>PA</given-names></name><name><surname>Dionysius</surname><given-names>DA</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name></person-group>. <article-title>Antibacterial activity of bovine lactoferrin-derived peptides</article-title>. <source>Antimicrob Agents Chemother.</source> (<year>1997</year>) <volume>41</volume>:<fpage>54</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.41.1.54</pub-id><?supplied-pmid 8980754?><pub-id pub-id-type="pmid">8980754</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>SD</given-names></name><name><surname>Beverly</surname><given-names>RL</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Dallas</surname><given-names>DC</given-names></name></person-group>. <article-title>Milk bioactive peptide database: a comprehensive database of milk protein-derived bioactive peptides and novel visualization</article-title>. <source>Food Chem.</source> (<year>2017</year>) <volume>232</volume>:<fpage>673</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2017.04.056</pub-id><?supplied-pmid 28490127?><pub-id pub-id-type="pmid">28490127</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group>. <article-title>APD3: the antimicrobial peptide database as a tool for research and education</article-title>. <source>Nucleic Acids Res.</source> (<year>2016</year>) <volume>44</volume>:<fpage>1087</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1278</pub-id><?supplied-pmid 26602694?><pub-id pub-id-type="pmid">26602694</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montagna</surname><given-names>MT</given-names></name><name><surname>Diella</surname><given-names>G</given-names></name><name><surname>Triggiano</surname><given-names>F</given-names></name><name><surname>Caponio</surname><given-names>GR</given-names></name><name><surname>De Giglio</surname><given-names>O</given-names></name><name><surname>Caggianon</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Chocolate, &#x0201c;food of the gods&#x0201d;: history, science, and human health</article-title>. <source>Int J Environ Res Public Health.</source> (<year>2019</year>) <volume>16</volume>:<fpage>4960</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph16244960</pub-id><?supplied-pmid 31817669?><pub-id pub-id-type="pmid">31817669</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarka</surname><given-names>SM</given-names></name><name><surname>Morrissey</surname><given-names>RB</given-names></name><name><surname>Apgar</surname><given-names>JL</given-names></name><name><surname>Hostetler</surname><given-names>KA</given-names></name><name><surname>Shively</surname><given-names>CA</given-names></name></person-group>. <article-title>Chronic toxicity/carcinogenicity studies of cocoa powder in rats</article-title>. <source>Food Chem Toxic.</source> (<year>1991</year>) <volume>29</volume>:<fpage>7</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/0278-6915(91)90057-E</pub-id><?supplied-pmid 1999308?><pub-id pub-id-type="pmid">1999308</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Ballotey-babington</surname><given-names>L</given-names></name><name><surname>Kwapong</surname><given-names>A</given-names></name><name><surname>N'Guessan</surname><given-names>B</given-names></name><name><surname>Amponsah</surname><given-names>S</given-names></name><name><surname>Asiedu-Gyekye</surname><given-names>I</given-names></name></person-group>
<article-title>Unsweetened natural cocoa powder: a potent nutraceutical in perspective</article-title>. <source>IntechOpen.</source> (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.intechopen.com/books/theobroma-cacao-deploying-science-for-sustainability-of-global-cocoa-economy/unsweetened-natural-cocoa-powder-a-potent-nutraceutical-in-perspective">https://www.intechopen.com/books/theobroma-cacao-deploying-science-for-sustainability-of-global-cocoa-economy/unsweetened-natural-cocoa-powder-a-potent-nutraceutical-in-perspective</ext-link> (accessed October 26, 2020).</mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Qi</surname><given-names>R</given-names></name><name><surname>Mine</surname><given-names>Y</given-names></name></person-group>
<article-title>The impact of oolong and black tea polyphenols on human health</article-title>. <source>Food Biosci</source>. (<year>2019</year>) <volume>29</volume>:<fpage>55</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.fbio.2019.03.009</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Zhang</surname><given-names>JS</given-names></name></person-group>. <article-title>Studies on the prevention of cancer and cardiometabolic diseases by tea: issues on mechanisms, effective doses, and toxicities</article-title>. <source>J Agri. Food Chem.</source> (<year>2019</year>) <volume>67</volume>:<fpage>5446</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.8b05242</pub-id><?supplied-pmid 30541286?><pub-id pub-id-type="pmid">30541286</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sergi</surname><given-names>C</given-names></name></person-group>. <article-title>Epigallocatechin-3-gallate toxicity in children: a potential and current toxicological event in the differential diagnosis with virus-triggered fulminant hepatic failure</article-title>. <source>Front Pharmacol.</source> (<year>2020</year>) <volume>10</volume>:<fpage>1563</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.01563</pub-id><?supplied-pmid 32063842?><pub-id pub-id-type="pmid">32063842</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>United States Food and Drug Administration (US FDA)</collab></person-group>
<source>CFR &#x02013; Code of Federal Regulations Title 21</source>. (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=184&#x00026;showFR=1">https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=184&#x00026;showFR=1</ext-link> (accessed October 26, 2020).</mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>United States Food and Drug Administration (USFDA)</collab></person-group>
<source>Dietary Supplements</source>. (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/food/dietary-supplements">https://www.fda.gov/food/dietary-supplements</ext-link> (accessed October 26, 2020).</mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title><italic>Cinnamomum cassia</italic> Presl: a review of its traditional uses, phytochemistry, pharmacology and toxicology</article-title>. <source>Molecules</source>. (<year>2019</year>) <volume>24</volume>:<fpage>3473</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24193473</pub-id><?supplied-pmid 31557828?><pub-id pub-id-type="pmid">31557828</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singletary</surname><given-names>K</given-names></name></person-group>
<article-title>Cinnamon. Update of potential health benefits</article-title>. <source>Nutr Today.</source> (<year>2019</year>) <volume>54</volume>:<fpage>42</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/NT.0000000000000319</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajimonfarednejad</surname><given-names>M</given-names></name><name><surname>Ostovar</surname><given-names>M</given-names></name><name><surname>Raee</surname><given-names>MJ</given-names></name><name><surname>Hashempur</surname><given-names>MH</given-names></name><name><surname>Mayer</surname><given-names>JG</given-names></name><name><surname>Heydari</surname><given-names>M</given-names></name></person-group>. <article-title>Cinnamon: a systematic review of adverse events</article-title>. <source>Clin Nutr.</source> (<year>2019</year>) <volume>38</volume>:<fpage>594</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2018.03.013</pub-id><?supplied-pmid 29661513?><pub-id pub-id-type="pmid">29661513</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singletary</surname><given-names>K</given-names></name></person-group>
<article-title>Vanilla. Potential health benefits</article-title>. <source>Nutr Today.</source> (<year>2020</year>) <volume>55</volume>:<fpage>186</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1097/NT.0000000000000412</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Assendelft</surname><given-names>A</given-names></name></person-group>. <article-title>Bronchospasm induced by vanillin and lactose</article-title>. <source>Eur J Respir Dis</source>. (<year>1984</year>) <volume>65</volume>:<fpage>468</fpage>&#x02013;<lpage>72</lpage>.<?supplied-pmid 6468546?><pub-id pub-id-type="pmid">6468546</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XS</given-names></name><name><surname>Xue</surname><given-names>YS</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>HL</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>BG</given-names></name><etal/></person-group>. <article-title>Occupational contact dermatitis in manufacture of vanillin</article-title>. <source>Chin Med J.</source> (<year>1987</year>) <volume>100</volume>:<fpage>250</fpage>&#x02013;<lpage>4</lpage>.<?supplied-pmid 2957179?><pub-id pub-id-type="pmid">2957179</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group>
<source>Evaluations of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)</source>. (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/food-additives-contaminants-jecfa-database/search.aspx">https://apps.who.int/food-additives-contaminants-jecfa-database/search.aspx</ext-link> (accessed October 26, 2020).</mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>GC</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name></person-group>. <article-title>Use of lipids in neonates requiring parenteral nutrition</article-title>. <source>J Parenter Enteral Nutr.</source> (<year>2020</year>) <volume>44</volume>:<fpage>45</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/jpen.1759</pub-id><?supplied-pmid 32049399?><pub-id pub-id-type="pmid">32049399</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maher</surname><given-names>T</given-names></name><name><surname>Clegg</surname><given-names>ME</given-names></name></person-group>. <article-title>A systematic review and meta-analysis of medium-chain triglycerides effects on acute satiety and food intake</article-title>. <source>Crit Rev Food Sci Nutr.</source> (<year>2020</year>) <volume>26</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2020.1742654</pub-id><?supplied-pmid 32212947?><pub-id pub-id-type="pmid">32212947</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food) Mortensen A Aguilar F Crebelli R Di Domenico A Dusemund B Frutos MJ </collab></person-group>. <article-title>Scientific opinion on the re-evaluation of fatty acids (E 570) as a food additive</article-title>. <source>EFSA J.</source> (<year>2017</year>) <volume>15</volume>:<fpage>4785</fpage>. <pub-id pub-id-type="doi">10.2903/j.efsa.2017.4785</pub-id><?supplied-pmid 32625490?><pub-id pub-id-type="pmid">32625490</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarghandian</surname><given-names>S</given-names></name><name><surname>Azimi-Nezhad</surname><given-names>M</given-names></name><name><surname>Farkhondeh</surname><given-names>T</given-names></name></person-group>. <article-title>Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells</article-title>. <source>J Cell Physiol.</source> (<year>2019</year>) <volume>234</volume>:<fpage>10421</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27710</pub-id><?supplied-pmid 30387147?><pub-id pub-id-type="pmid">30387147</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>M</given-names></name><name><surname>Bresgen</surname><given-names>N</given-names></name><name><surname>Eckl</surname><given-names>PM</given-names></name></person-group>. <article-title><italic>In vitro</italic> toxicological properties of thymoquinone</article-title>. <source>Food Chem Toxicol.</source> (<year>2009</year>) <volume>47</volume>:<fpage>129</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2008.10.019</pub-id><?supplied-pmid 19010375?><pub-id pub-id-type="pmid">19010375</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dollah</surname><given-names>HMA</given-names></name><name><surname>Parhizkar</surname><given-names>S</given-names></name><name><surname>Latiff</surname><given-names>LA</given-names></name><name><surname>Hassan</surname><given-names>MHB</given-names></name></person-group>. <article-title>Toxicity effect of <italic>Nigella sativa</italic> on the liver function of rats</article-title>. <source>Adv Pharm Bull.</source> (<year>2013</year>) <volume>3</volume>:<fpage>97</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.5681/apb.2013.016</pub-id><?supplied-pmid 24312819?><pub-id pub-id-type="pmid">24312819</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmani</surname><given-names>AH</given-names></name><name><surname>Alzohairy</surname><given-names>MA</given-names></name><name><surname>Khan</surname><given-names>MA</given-names></name><name><surname>Aly</surname><given-names>SM</given-names></name></person-group>. <article-title>Therapeutic implications of black seed and its constituent TQ in the prevention of cancer through inactivation and activation of molecular pathways</article-title>. <source>Evid Based Complement Alternat Med.</source> (<year>2014</year>) <volume>2014</volume>:<fpage>724658</fpage>. <pub-id pub-id-type="doi">10.1155/2014/724658</pub-id><?supplied-pmid 24959190?><pub-id pub-id-type="pmid">24959190</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Kumar</surname><given-names>KJS</given-names></name><name><surname>Liao</surname><given-names>JW</given-names></name><name><surname>Kuo</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>SY</given-names></name></person-group>. <article-title>Genotoxic, teratotoxic and oral toxic assessments of <italic>Antrodia cinnamomea</italic> health food product [Leader Deluxe Antrodia cinnamomea (R)]</article-title>. <source>Toxicol Rep.</source> (<year>2015</year>) <volume>2</volume>:<fpage>1409</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxrep.2015.10.007</pub-id><?supplied-pmid 28962482?><pub-id pub-id-type="pmid">28962482</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Brody</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>G-H</given-names></name><name><surname>Rang&#x000e9;</surname><given-names>H</given-names></name><name><surname>Kuraji</surname><given-names>R</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Probiotics, including nisin-based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases</article-title>. <source>Periodontol.</source> (<year>2000</year>) <volume>82</volume>:<fpage>173</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12324</pub-id><?supplied-pmid 31850634?><pub-id pub-id-type="pmid">31850634</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>G</given-names></name><name><surname>Silva</surname><given-names>GGO</given-names></name><name><surname>Buccini</surname><given-names>DF</given-names></name><name><surname>Duque</surname><given-names>HM</given-names></name><name><surname>Dias</surname><given-names>SC</given-names></name><name><surname>Franco</surname><given-names>OL</given-names></name></person-group>. <article-title>Bacterial proteinaceous compounds with multiple activities toward cancers and microbial infection</article-title>. <source>Front Microbiol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1690</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.01690</pub-id><?supplied-pmid 31447795?><pub-id pub-id-type="pmid">31447795</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>N</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Inai</surname><given-names>T</given-names></name></person-group>. <article-title>Nisin, a food preservative produced by <italic>Lactococcus lactis</italic>, affects the localization pattern of intermediate filament protein in HaCaT cells</article-title>. <source>Anat Sci Int</source>. (<year>2019</year>) <volume>94</volume>:<fpage>163</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1007/s12565-018-0462-x</pub-id><?supplied-pmid 30353456?><pub-id pub-id-type="pmid">30353456</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorlewska-Roberts</surname><given-names>KM</given-names></name><name><surname>Teitel</surname><given-names>CH</given-names></name><name><surname>Lay</surname><given-names>JO</given-names><suffix>Jr</suffix></name><name><surname>Roberts</surname><given-names>DW</given-names></name><name><surname>Kadlubar</surname><given-names>FF</given-names></name></person-group>. <article-title>Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines</article-title>. <source>Chem Res Toxicol.</source> (<year>2004</year>) <volume>17</volume>:<fpage>1659</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1021/tx049787n</pub-id><?supplied-pmid 15606142?><pub-id pub-id-type="pmid">15606142</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Serie</surname><given-names>MM</given-names></name><name><surname>El-Fakharany</surname><given-names>EM</given-names></name></person-group>. <article-title>Efficiency of novel nanocombinations of bovine milk proteins (lactoperoxidase and lactoferrin) for combating different human cancer cell lines</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>16769</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-16962-6</pub-id><?supplied-pmid 29196676?><pub-id pub-id-type="pmid">29196676</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>Y</given-names></name><name><surname>Ono</surname><given-names>A</given-names></name><name><surname>Serizawa</surname><given-names>A</given-names></name><name><surname>Yogo</surname><given-names>K</given-names></name><name><surname>Ishida-Kitagawa</surname><given-names>N</given-names></name><name><surname>Takeya</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Purification and identification of lactoperoxidase in milk basic proteins as an inhibitor of osteoclastogenesis</article-title>. <source>J Dairy Sci</source>. (<year>2011</year>) <volume>94</volume>:<fpage>2270</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2010-4039</pub-id><?supplied-pmid 21524516?><pub-id pub-id-type="pmid">21524516</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>JA</given-names></name><name><surname>Kanwar</surname><given-names>JR</given-names></name><name><surname>Kanwar</surname><given-names>RK</given-names></name></person-group>. <article-title>Iron-free and iron-saturated bovine lactoferrin inhibit surviving expression and differentially modulate apoptosis in breast cancer</article-title>. <source>BMC Cancer</source>. (<year>2015</year>) <volume>15</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s12885-015-1441-4</pub-id><?supplied-pmid 25998617?><pub-id pub-id-type="pmid">25971837</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzoni</surname><given-names>P</given-names></name></person-group>. <article-title>Clinical benefits of lactoferrin for infants and children</article-title>. <source>J Pediatr.</source> (<year>2016</year>) <volume>173</volume>:<fpage>43</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2016.02.075</pub-id><?supplied-pmid 27234411?><pub-id pub-id-type="pmid">27234411</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telang</surname><given-names>S</given-names></name></person-group>. <article-title>Lactoferrin: a critical player in neonatal host defense</article-title>. <source>Nutrients</source>. (<year>2018</year>) <volume>10</volume>:<fpage>1228</fpage>. <pub-id pub-id-type="doi">10.3390/nu10091228</pub-id><?supplied-pmid 30181493?><pub-id pub-id-type="pmid">30181493</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motoki</surname><given-names>N</given-names></name><name><surname>Mizuki</surname><given-names>M</given-names></name><name><surname>Tsukahara</surname><given-names>T</given-names></name><name><surname>Miyakawa</surname><given-names>M</given-names></name><name><surname>Kubo</surname><given-names>S</given-names></name><name><surname>Oda</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Effects of lactoferrin-fortified formula on acute gastrointestinal symptoms in children aged 12-32 months: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Front Pediatr</source>. (<year>2020</year>) <volume>8</volume>:<fpage>233</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2020.00233</pub-id><?supplied-pmid 32509712?><pub-id pub-id-type="pmid">32509712</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamauchi</surname><given-names>K</given-names></name><name><surname>Toida</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name><name><surname>Nagano</surname><given-names>E</given-names></name><name><surname>Kusuoka</surname><given-names>O</given-names></name><name><surname>Teraguchi</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>13-week oral repeated administration toxicity study of bovine lactoferrin in rats</article-title>. <source>Food Chem Toxicol.</source> (<year>2000</year>) <volume>38</volume>:<fpage>503</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/S0278-6915(00)00036-3</pub-id><?supplied-pmid 10828502?><pub-id pub-id-type="pmid">10828502</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutone</surname><given-names>A</given-names></name><name><surname>Rosa</surname><given-names>L</given-names></name><name><surname>Ianiro</surname><given-names>G</given-names></name><name><surname>Lepanto</surname><given-names>MS</given-names></name><name><surname>Bonaccorsi di Patti</surname><given-names>MC</given-names></name><name><surname>Valenti</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Lactoferrin's anti-cancer properties: safety, selectivity, and wide range of action</article-title>. <source>Biomolecules</source>. (<year>2020</year>) <volume>10</volume>:<fpage>456</fpage>. <pub-id pub-id-type="doi">10.3390/biom10030456</pub-id><?supplied-pmid 32183434?><pub-id pub-id-type="pmid">32183434</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piqu&#x000e9;</surname><given-names>N</given-names></name><name><surname>Berlanga</surname><given-names>M</given-names></name><name><surname>Mi&#x000f1;ana-Galbis</surname><given-names>D</given-names></name><name><surname>Piqu&#x000e9;</surname><given-names>N</given-names></name><name><surname>Berlanga</surname><given-names>M</given-names></name><name><surname>Mi&#x000f1;ana-Galbis</surname><given-names>D</given-names></name></person-group>. <article-title>Health benefits of heat-killed (Tyndallized) probiotics: an overview</article-title>. <source>Int J Mol Sci</source>. (<year>2019</year>) <volume>20</volume>:<fpage>2534</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20102534</pub-id><?supplied-pmid 31126033?><pub-id pub-id-type="pmid">31126033</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Cho</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><etal/></person-group>. <article-title>Characterization of the anti-cancer activity of the probiotic bacterium <italic>Lactobacillus fermentum</italic> using 2D vs. 3D culture in colorectal cancer cells</article-title>. <source>Biomolecules.</source> (<year>2019</year>) <volume>9</volume>:<fpage>557</fpage>. <pub-id pub-id-type="doi">10.3390/biom9100557</pub-id><?supplied-pmid 31581581?><pub-id pub-id-type="pmid">31581581</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constable</surname><given-names>A</given-names></name><name><surname>Mahadevan</surname><given-names>B</given-names></name><name><surname>Pressman</surname><given-names>P</given-names></name><name><surname>Garthoff</surname><given-names>JA</given-names></name><name><surname>Meunier</surname><given-names>L</given-names></name><name><surname>Schrenk</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>An integrated approach to the safety assessment of food additives in early life</article-title>. <source>Toxicol Res Appl.</source> (<year>2017</year>) <volume>1</volume>:<fpage>1</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1177/2397847317707370</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>DL</given-names></name><name><surname>Doughty</surname><given-names>K</given-names></name><name><surname>Ali</surname><given-names>A</given-names></name></person-group>. <article-title>Cocoa and chocolate in human health and disease</article-title>. <source>Antioxid Redox Signal.</source> (<year>2011</year>)<volume>15</volume>:<fpage>2779</fpage>&#x02013;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2010.3697</pub-id><?supplied-pmid 21470061?><pub-id pub-id-type="pmid">21470061</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>TF</given-names></name><name><surname>Palomino</surname><given-names>OM</given-names></name><name><surname>&#x000c1;lvarez-Cilleros</surname><given-names>D</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>MA</given-names></name><name><surname>Ramos</surname><given-names>S</given-names></name><name><surname>Goya</surname><given-names>L</given-names></name></person-group>. <article-title>Cocoa flavanols protect human endothelial cells from oxidative stress</article-title>. <source>Plant Foods Hum Nutr.</source> (<year>2020</year>)<volume>75</volume>:<fpage>161</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s11130-020-00807-1</pub-id><?supplied-pmid 32185628?><pub-id pub-id-type="pmid">32185628</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cory</surname><given-names>H</given-names></name><name><surname>Passarelli</surname><given-names>S</given-names></name><name><surname>Szeto</surname><given-names>J</given-names></name><name><surname>Tamez</surname><given-names>M</given-names></name><name><surname>Mattei</surname><given-names>J</given-names></name></person-group>. <article-title>The role of polyphenols in human health and food systems: a mini-review</article-title>. <source>Front Nutr</source>. (<year>2018</year>) <volume>5</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3389/fnut.2018.00087</pub-id><?supplied-pmid 30298133?><pub-id pub-id-type="pmid">29564328</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>FF</given-names></name><name><surname>Xie</surname><given-names>JH</given-names></name><name><surname>Huang</surname><given-names>DF</given-names></name><name><surname>Xie</surname><given-names>MY</given-names></name></person-group>. <article-title>Fetal and neonatal genistein exposure aggravates to interfere with ovarian follicle development of obese female mice induced by high-fat diet</article-title>. <source>Food Chem Toxicol.</source> (<year>2020</year>) <volume>135</volume>:<fpage>110982</fpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2019.110982</pub-id><?supplied-pmid 31747621?><pub-id pub-id-type="pmid">31747621</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adgent</surname><given-names>AA</given-names></name><name><surname>Umbach</surname><given-names>DM</given-names></name><name><surname>Zemel</surname><given-names>BS</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name><name><surname>Schall</surname><given-names>JI</given-names></name><name><surname>Ford</surname><given-names>EG</given-names></name><etal/></person-group>. <article-title>Longitudinal study of estrogen-responsive tissues and hormone concentrations in infants fed soy formula</article-title>. <source>J Clin Endocrinol Metab.</source> (<year>2018</year>) <volume>103</volume>:<fpage>1899</fpage>&#x02013;<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2017-02249</pub-id><?supplied-pmid 29506126?><pub-id pub-id-type="pmid">29506126</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testa</surname><given-names>I</given-names></name><name><surname>Salvatori</surname><given-names>C</given-names></name><name><surname>Di Cara</surname><given-names>G</given-names></name><name><surname>Latini</surname><given-names>A</given-names></name><name><surname>Frati</surname><given-names>F</given-names></name><name><surname>Troiani</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Soy-based infant formula: are phyto-oestrogens still in doubt?</article-title>
<source>Front Nutr</source>. (<year>2018</year>) <volume>5</volume>:<fpage>110</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2018.00110</pub-id><?supplied-pmid 30533415?><pub-id pub-id-type="pmid">30533415</pub-id></mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>RG</given-names></name><name><surname>Clark</surname><given-names>RM</given-names></name><name><surname>Ferris</surname><given-names>AM</given-names></name></person-group>. <article-title>Composition of the lipids in human milk: a review</article-title>. <source>Lipids.</source> (<year>1980</year>) <volume>15</volume>:<fpage>345</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1007/BF02533550</pub-id><?supplied-pmid 6993828?><pub-id pub-id-type="pmid">6993828</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hageman</surname><given-names>JH</given-names></name><name><surname>Danielsen</surname><given-names>M</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>AG</given-names></name><name><surname>Feitsma</surname><given-names>AL</given-names></name><name><surname>Dalsgaard</surname><given-names>TK</given-names></name></person-group>
<article-title>Comparison of bovine milk fat and vegetable fat for infant formula: implications for infant health</article-title>. <source>Int Dairy J.</source> (<year>2019</year>) <volume>92</volume>:<fpage>37</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.idairyj.2019.01.005</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiner</surname><given-names>L</given-names></name><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Ortner</surname><given-names>E</given-names></name><name><surname>Buettner</surname><given-names>A</given-names></name></person-group>. <article-title>Structure&#x02013;odor activity studies on derivatives of aromatic and oxygenated monoterpenoids synthesized by modifying p-cymene</article-title>. <source>J Nat Prod.</source> (<year>2020</year>) <volume>83</volume>:<fpage>834</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b00339</pub-id><?supplied-pmid 32196341?><pub-id pub-id-type="pmid">32196341</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younes</surname><given-names>M</given-names></name><name><surname>Aggett</surname><given-names>P</given-names></name><name><surname>Aguilar</surname><given-names>F</given-names></name><name><surname>Crebelli</surname><given-names>R</given-names></name><name><surname>Dusemund</surname><given-names>B</given-names></name><name><surname>Filipi&#x0010d;</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use</article-title>. <source>EFSA J.</source> (<year>2017</year>) <volume>15</volume>:<fpage>5063</fpage>. <pub-id pub-id-type="doi">10.2903/j.efsa.2017.5063</pub-id><?supplied-pmid 32625365?><pub-id pub-id-type="pmid">32625365</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>J G</given-names></name><name><surname>Board</surname><given-names>RG</given-names></name></person-group>
<article-title>Preservation by the lactoperoxidase system (LP-S) of a contaminated infant milk formula</article-title>. <source>Lett Appl Microbiol.</source> (<year>1985</year>) <volume>1</volume>:<fpage>81</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.1985.tb01495.x</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Masano</surname><given-names>H</given-names></name><name><surname>Okuyama</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Kawase</surname><given-names>K</given-names></name></person-group>
<article-title>Effect of lactoferrin-enriched infant formula on low birth weight infants</article-title>. <source>Shuusankiigaku.</source> (<year>1989</year>)<volume>19</volume>:<fpage>125</fpage>&#x02013;<lpage>30</lpage>.</mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakabayashi</surname><given-names>H</given-names></name><name><surname>Yamauchi</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>F</given-names></name></person-group>. <article-title>Quality control of commercial bovine lactoferrin</article-title>. <source>BioMetals.</source> (<year>2018</year>) <volume>31</volume>:<fpage>313</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s10534-018-0098-2</pub-id><?supplied-pmid 29619653?><pub-id pub-id-type="pmid">29619653</pub-id></mixed-citation></ref><ref id="B164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mennella</surname><given-names>JA</given-names></name><name><surname>Beauchamp</surname><given-names>GK</given-names></name></person-group>. <article-title>The human infants' responses to vanilla flavors in human milk and formula</article-title>. <source>Infant Behav Dev.</source> (<year>1996</year>) <volume>19</volume>:<fpage>13</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0163-6383(96)90040-5</pub-id><?supplied-pmid 7748264?><pub-id pub-id-type="pmid">7748264</pub-id></mixed-citation></ref><ref id="B165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beauchamp</surname><given-names>GK</given-names></name><name><surname>Mennella</surname><given-names>JA</given-names></name></person-group>. <article-title>Early flavor learning and its impact on later feeding behavior</article-title>. <source>J Pediatr Gastr Nutr.</source> (<year>2009</year>) <volume>48</volume>:<fpage>25</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0b013e31819774a5</pub-id><?supplied-pmid 19214055?><pub-id pub-id-type="pmid">19214055</pub-id></mixed-citation></ref><ref id="B166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valencia</surname><given-names>GA</given-names></name><name><surname>Zare</surname><given-names>EN</given-names></name><name><surname>Makvandi</surname><given-names>P</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>TJ</given-names></name></person-group>
<article-title>Self-assembled carbohydrate polymers for food applications: a review</article-title>. <source>Compr Rev Food Sci Food Saf</source>. (<year>2019</year>) <volume>18</volume>:<fpage>2009</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/1541-4337.12499</pub-id></mixed-citation></ref><ref id="B167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampathkumar</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>KX</given-names></name><name><surname>Loo</surname><given-names>SCJ</given-names></name></person-group>
<article-title>Developing nano-delivery systems for agriculture and food applications with nature-derived polymers</article-title>. <source>iScience</source>. (<year>2020</year>) <volume>23</volume>:<fpage>101055</fpage>
<pub-id pub-id-type="doi">10.1016/j.isci.2020.101055</pub-id><pub-id pub-id-type="pmid">32339991</pub-id></mixed-citation></ref><ref id="B168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>HS</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>JC</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name></person-group>
<article-title>Antimicrobials from mushrooms for assuring food safety</article-title>. <source>Compr Rev Food Sci Food Saf.</source> (<year>2017</year>) <volume>16</volume>:<fpage>316</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1111/1541-4337.12255</pub-id></mixed-citation></ref></ref-list></back></article>